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ABSTRACT
Dietary restriction (DR), the limitation of food intake below the ad libidum (AL)
level without malnutrition, extends mean and maximum lifespan in every organism in
which it has been tested. Perhaps even more significantly, DR has also been shown in
animal models to slow progression of, or even prevent entirely, an array of age-dependent
pathologies, including cardiovascular disease, multiple types of cancer, several
neurodegenerative disorders, and diabetes. Short-term DR also reduces the risk of
coronary disease and stroke in humans. Clearly, identification of the genetic mechanisms
underlying these protective effects of DR would have profound implications for the
development of novel medical interventions affecting diseases of aging.
Recent studies of model organisms have revealed many genetic pathways that
control the physiological rate of aging. However, advances in understanding DR
longevity have lagged behind, especially in metazoans. Here, I use the roundworm C.
elegans as a model of DR longevity and identify some of the underlying genetic
mechanisms.
DR profoundly alters endocrine function in mammals, but no causal role of any
hormonal signal in DR longevity has been demonstrated. I show that increased longevity
of diet-restricted C. elegans requires the transcription factor skn-1 acting specifically in
the ASIs, a pair of neurons in the head. DR activates skn-1 in the ASIs, which signals
peripheral tissues to increase metabolic activity. These findings demonstrate that
increased lifespan in a diet-restricted metazoan depends on cell-nonautonomous signaling
from central neuronal cells to non-neuronal body tissues, and suggest that the ASIs
mediate dietary restriction-induced longevity by an endocrine mechanism.
Next, I identify sek-1, a conserved stress-responsive MAPKK, as essential for
DR-induced longevity and several other physiological responses to DR. I show that sek-1
acts in the ASI neurons to maintain skn-1 expression and mediate the DR longevity
response. sek-1 functions downstream of the MAPKKK nsy-1 during DR. Thus,
activation of a stress-sensitive MAPK pathway in the brain may be a crucial initial event
in DR-induced longevity.
To summarize, I have established a three-member genetic pathway that mediates
DR longevity by acting in the ASI neurons of C. elegans.
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CHAPTER 1
Dietary Restriction-Induced Longevity in Model Organisms
and the Hypothesis of Neuroendocrine Control
Portions of this chapter will be submitted for publication. The authors will be Nicholas
A. Bishop and Leonard Guarente.

Dietary restriction: an intervention that extends healthy lifespan
Dietary restriction (DR), the limitation of food intake below the ad libidum (AL)
level without malnutrition, extends mean and maximum lifespan in every organism in
which it has been tested, including yeast', worms2, flies3, and rodents4 . Studies are
presently underway to test the effect of DR on lifespan in primates, with promising
preliminary results5. Perhaps even more significantly, DR has also been shown in animal
models to slow progression of, or even prevent entirely, an array of age-dependent
pathologies, including cardiovascular disease6 , multiple types of cancer7 , several
neurodegenerative disorders8', 9, and diabetes'0 . Short-term DR also reduces the risk of
coronary disease and stroke in humans6. Clearly, identification of the genetic
mechanisms underlying these protective effects of DR would have profound implications
for the development of novel medical interventions affecting diseases of aging. DR
induces alterations in the physiology of many organ systems in rodents, which have been
characterized extensively over the last several decades". However, which of these
myriad changes are causally relevant in the increased longevity and improved health of
DR animals has remained elusive.
Studies in model organisms can identify single genes controlling aging
In contrast to the limited progress on DR longevity specifically, the last fifteen
years have seen a great deal learned about the general genetic regulation of aging in
model organisms, principally the yeast S. cerevisiae, the worm C. elegans, and the
fruitfly D. melanogaster. Studies of these organisms have revealed that aging is not
simply an inevitable "wearing out" of the body with time, but a regulated process
controlled by a few critical genetic pathways. The rate of physiological aging can be
modulated by a relatively small set of regulatory genes, defining several general
pathways of lifespan control, many of which are conserved across taxa even unto
mammals (Figure 1). A very well-characterized and conserved longevity intervention is
reduced insulin-IGF axis signaling. Insulin signaling was first determined to be a
lifespan control pathway when the worm gene daf-2, mutation of which was known to
cause increased lifespan, was cloned and found to encode a homologue of the insulin
receptor 2. Reduced insulin-IGF axis signaling has since been shown also to extend
lifespan in flies and mice 3.Most other interventions that extend lifespan have also first
been identified in C. elegans, including germline ablation 14, sensory neuron defects 15, and
reduced mitochondrial function during development1 6, among others. The worm model
permits systematic whole-genome RNAi screens for genes affecting longevity' 7' 18, the
results of which have led some investigators to suggest that "we may now be aware of
most of the major biological pathways in C. elegans that, when inhibited, can produce
large extensions in lifespan'"." It is therefore perhaps surprising that, unlike most other
mechanisms of aging control, almost nothing is known of the genetic control of lifespan
extension by dietary restriction in any metazoan, including C. elegans.
Studying DR in C. elegans
The first genetic determinants of DR longevity were identified seven years ago
using yeast as a model system, and now quite robust genetic pathways controlling DR
longevity in yeast have been elucidated (see below). The lagging progress on genetic
control of DR longevity in C. elegans is likely due largely to the relative technical
difficulty of inducing DR in the worm. One method of achieving DR has been the use of
eat-2 mutant strains, which have a reduced rate of pharyngeal pumping and reduced food
ingestion19. eat-2 mutants have been reported to live up to 50% longer than wild-type20
but in the hands of the author and others 21 the lifespan extension is much shorter or
absent (data not shown). Thus, DR by eat-2 mutation seems unreliable. The eat-2
method of DR is also potentially subject to confounding effects during development
under DR that might influence adult lifespan, as well as a dichotomy between low food in
the worm and high food in the environment. The other reported method of inducing DR
in worms is growth in liquid medium with controlled high or low bacterial density2. This
method is limited in that it does not lend itself to the traditional form of the worm
lifespan assay, which is to follow a population of a few dozen individuals throughout its
entire lifespan. This limitation, along with the use of medium and culture conditions that
differ substantially from standard worm plates, complicates comparisons to existing
studies on any given mutant. Furthermore, the magnitude of lifespan extension induced
by this liquid culture approach has been underwhelming in most recent reports22. To
address the shortcomings of existing DR induction approaches, I developed a novel
method of inducing DR in C. elegans based on culture in a few milliliters of liquid with
controlled bacterial density (Chapter 2). This method permits monitoring of a population
of individuals during the entire lifespan and produces a robust and extremely
reproducible lifespan extension. Furthermore, the composition of the medium differs
from plates only by the exclusion of agar, and wild type and mutant worms show a
similar lifespan in high food concentration liquid culture as they do on plates, permitting
reasonably direct comparison of studies in my DR conditions and those done on
traditional plates.
Using this novel method, I screened strains carrying mutants in known or
candidate longevity genes (Chapter 3 and data not shown). Initially, this work
demonstrated that DR extends lifespan in representative mutant backgrounds covering
essentially all known lifespan-control pathways. These results argue that DR extends
lifespan by a mechanism different from known longevity pathways. Continuing the
candidate gene approach, I identified a novel genetic pathway specifically required for
DR-induced longevity (Chapters 2 and 3). Analysis of this genetic pathway revealed that
it functions exclusively in a pair of neuroendocrine cells in the head, called the ASI
neurons, to mediate DR longevity.
A conserved neural basis for DR longevity?
The discovery that cell-nonautonomous signaling from central neurons mediates
DR longevity in a metazoan represents the central conceptual advance of this thesis. For
the remainder of this chapter, I will review other recent findings that are beginning to
point toward a conserved neural basis of DR longevity control across species. By this
comparative approach, I hope to provide the reader with the relevant background on what
is known and suspected about the control of DR longevity in different model organisms.
I also hope the reader will be inspired to share my excitement over the tantalizing
evidence that the emerging mechanisms of DR longevity control in lower organisms will
prove to be conserved in mammals.
Current evidence strongly suggests that DR is mediated by brain neurons that
sense energy availability and translate energy limitation into longevity during DR.
In mammals, homeostatic energy balance is principally monitored and maintained by a
brain region called the hypothalamus. The hypothalamus senses changes in energy
balance and reflexively modulates energy intake and expenditure, by altering feeding
behavior and peripheral metabolism, respectively. Here I present evidence supporting the
hypothesis that increased longevity induced by DR is also controlled by the
hypothalamus. I begin by reviewing the current understanding of the genetic
mechanisms of energy sensing in the mammalian hypothalamus. I then outline the known
pathways mediating DR longevity in the organism in which they are best-understood,
yeast, and highlight similarities between mechanisms of hypothalamic energy sensing
and DR longevity in yeast. I describe recent direct evidence for central neuronal control
of dietary restriction-induced longevity in worms, flies, and mammals. Finally, I identify
potential novel DR genes based on their role in both invertebrate lifespan control and
hypothalamic energy sensing.
Hypothalamic energy sensing in mammals
The hypothalamus is the principal vertebrate brain region responsible for
maintaining homeostatic energy balance. The hypothalamus detects changes in energy
availability and mediates appropriate modifications of energy intake and expenditure
(Figure 2a). Specifically, the hypothalamus modulates energy balance by causing
behavioral responses to hunger, such as increased feeding and foraging, and can alter
energy expenditure in peripheral tissues via efferent hormonal and autonomic nervous
signaling. In addition, the hypothalamus controls other nutrient-dependent processes such
as growth, sexual maturation and reproduction. Very recently, the hypothalamus has been
proven also to be capable of controlling mammalian lifespan (see below). Much has been
learned about the genetic mechanisms of hypothalamic energy sensing in recent years, an
overview of which will be presented here. The reader is directed to several recent reviews
for further detail23 25.
Energy-sensing hypothalamic nuclei and neuropeptides
The behavior- and metabolism-modifying outputs of the hypothalamus result
from the integrated activity of several populations of energy-sensitive neurons (Figure
2b). The best characterized of these are two neuronal populations within the arcuate
nucleus: the anorexigenic proopiomelanocortin (POMC) neurons and the orexigenic
agouti-related peptide (AgRP) neurons. When energy is in excess, AgRP neurons are
repressed, while POMC neurons are active and release alpha-melanocyte stimulating
hormone (a-MSH), which is a product of POMC proteolytic cleavage. a-MSH is an
agonist of the melanocortin 4 receptor (MC4R), which is expressed in neurons of the
paraventricular and ventromedial hypothalamus. Activation of MC4R causes reduced
energy intake and increased peripheral energy expenditure, restoring homeostatic energy
balance. When energy availability is low, POMC neurons are repressed, while AgRP
neurons are activated, causing increased release of AgRP, an antagonist of MC4R that
reduces its activity and promotes increased feeding and decreased peripheral energy
expenditure. Knockout of MC4R causes hyperphagia and obesity26, while ablation of
AgRP neurons in adults suppresses feeding27, confirming the critical role of this pathway
in regulating energy balance.
In addition to the neurons already described, two populations of neurons in the
lateral hypothalamus, expressing either hypocretin (Hcrt) or melanin concentrating
hormone (MCH), also play a role in promoting feeding, as ablation of either the MCH
gene or the Hcrt neurons causes hypophagia and altered energy expenditure28' 29. The
hypocretin neurons also appear to have complex roles in the regulation of arousal, as
deletion of Hcrt causes narcolepsy30
Cell-intrinsic sensing of energy availability
Hypothalamic neurons integrate information from several sources in order to
generate an overall picture of organismal energy status. One mechanism by which
hypothalamic neurons sense energy availability is the sampling of levels of certain key
metabolites within the cell, including glucose, fatty acids, ATP, and possibly amino acids
(Figure 3).
The hypothalamus contains many glucose-sensitive neurons, which are either
glucose-excited or glucose-inhibited. For example, anorexigenic POMC neurons are
glucose-excited 3 1 and orexigenic AgRP neurons are glucose-inhibited 32. Glucose-excited
hypothalamic neurons sense glucose concomitantly with its metabolism, in a manner
analogous to that of pancreatic P cells (Figure 3a). Most glucose-sensitive hypothalamic
neurons, unlike most other brain neurons, express the pancreatic form of glucokinase,
which is required for glucose sensing in both neurons and P-cells33. Glycolysis produces
pyruvate and elevates cytoplasmic NADH. Both metabolites must be produced and
transported into the mitochondria for glucose to be sensed 34. NADH and pyruvate in the
mitochondria cause increased ATP production, which closes ATP-sensitive potassium
channels, leading ultimately, in neurons, to increased action potential frequency. The
mechanism of glucose inhibition in glucose-inhibited neurons is not as well understood,
though pancreatic glucokinase activity and production of cytoplasmic NADH by
glycolysis are essential for glucose sensing in these cells also 35
To an even greater degree than glucose, perception of energy status by
hypothalamic neurons depends on the intracellular levels of certain intermediates of fatty
acid metabolism 24 (Figure 3b). Experimental manipulation that results in a constitutively
low intracellular level of long-chain fatty acyl-CoA (LFCA) molecules in hypothalamic
neurons is sufficient to increase expression of AgRP, cause hyperphagia, and decrease
peripheral energy expenditure, leading to obesity36. Physiological control of LCFA level
is heavily dependent on the steady-state level of malonyl-CoA, an intermediate in fatty
acid biosynthesis. In the absence of malonyl-CoA, LCFA-CoAs are transported by
carnitine-palmitoyl transferase 1 (CPT ) into the mitochondria for 3-oxidation. When
malonyl-CoA is abundant, CPT1 is inhibited and LCFA-CoA levels remain high,
promoting anorexigenic hypothalamic outputs24.
Malonyl-CoA is produced from acetyl-CoA by acetyl-CoA carboxylase (ACC).
ACC is primarily regulated via inhibitory phosphorylation by AMP-activated protein
kinase (AMPK), which is activated by low ATP levels in most eukaryotic cells37. AMPK
controls hypothalamic energy sensing, acting both to promote expression of orexigenic
peptides in the arcuate nucleus and to promote appropriate response in the paraventricular
receiving cells 38. AMPK is thought to act in part by inhibiting ACC and thus reducing
malonyl-CoA levels. mTOR has recently been shown to inhibit food intake by acting in
the hypothalamus, particularly in response to injected leucine39. AMPK is an important
inhibitor of mTOR in many tissues, and therefore may exert its hypothalamic effects on
energy homeostasis in part by inhibition of mTOR40 .
Recently, it was shown that fasting induces expression of uncoupling protein 2
(UCP2) in AgRP neurons41. Uncoupling proteins reduce metabolic efficiency by
dissipating the proton gradient across the mitochondrial membrane, necessitating more
rapid respiration to maintain ATP production rate. Fasting also caused an increase in
mitochondrial number in the AgRP neurons, perhaps to compensate for this reduced
metabolic efficiency. In UCP2 KO animals, fasting did not cause mitochondrial
uncoupling or biogenesis, orexigenic peptide expression was not induced by fasting, and
rebound feeding following fasting was diminished. Thus, fasting-induced uncoupling of
mitochondrial respiration is a critical step in activation of orexigenic AgRP neurons. It is
not known how increased uncoupling in these neurons leads to perception of a low-
energy state, but it is worth noting that increased uncoupling should lower NADH levels
and/or ATP levels, possibly reducing glucose inhibition and/or increasing AMPK activity
by the mechanisms discussed above.
Afferent hormones modulate hypothalamic energy sensing
In addition to the essentially cell-intrinsic energy sensing mechanisms described
above, hypothalamic energy sensing pathways are modulated by an ever-expanding
group of afferent hormones carrying information about the long- and short-term energy
status of the body23 . I will limit my discussion to two of the most important, leptin and
insulin.
Leptin is produced by adipocytes in proportion to fat mass, and promotes anorexic
hypothalamic signaling23. Mutation of the leptin gene ob causes hyperphagia and
massive obesity42, due in large part to repression of AgRP neurons and activation of
POMC neurons 23' 43. The binding of leptin to its receptors on arcuate neurons activates
the transcription factor Stat3 and also activates PI3 kinase, which promotes Akt-
dependent phosphorylation and nuclear exclusion of the transcription factor FoxO 144
(Figure 4). Stat3 and FoxOl oppositely regulate orexigenic and anorexigenic
neuropeptide gene expresssion.
Insulin also promotes hypothalamic anorexigenic signaling, but plays a more
minor role than leptin. Neuron-specific insulin receptor knockout causes mild obesity45,
and central administration of insulin causes suppression of feeding46. Interestingly,
insulin signaling affects the PI3K-Akt-Foxo 1 cascade in the same direction as leptin
signaling in arcuate neurons, so it has been suggested that the insulin signaling pathway
may act to modulate the dominant leptin signal". Consistently with this model, Stat3 and
Foxol bind to partially overlapping sites on orexigenic and anorexigenic peptide gene
promoters and oppositely regulate them, providing a mechanism by which insulin
signaling could cooperate with leptin signaling by removing the repressive effect of
FoxO 147 (Figure 4). In addition, pharmacological inhibition of hypothalamic PI3 kinase
suppresses the effects of both leptin and insulin, indicating that leptin and insulin
signaling pathways converge on PI3K48' 49
Neuropeptide regulation is not the only mechanism by which leptin and insulin
promote hypothalamic anorexigenic signals. For instance, leptin and insulin both inhibit
hypothalamic AMPK signaling 38. Leptin also upregulates mTOR in the hypothalamus39.
Dietary restriction in yeast
The first genes involved in dietary restriction-induced lifespan increase were
identified in the yeast S. cerevisiae5o. In yeast, replicative lifespan is defined as the
number of daughter cells a mother cell can produce before senescing, and this lifespan is
controlled by many of the same genes that control metazoan lifespan. A report published
in 2000 showed that reducing glucose concentration in the medium from 2% to 0.5%
could extend replicative lifespan, establishing a model of DR in yeast5o. A number of
genes mediating this DR-induced longevity were identified using this model. More
recently, however, it has been found that more extreme glucose limitation, to 0.05%, can
apparently induce an entirely separate set of genes that mediate an even longer lifespan
extension 51-53 . The controversy surrounding the genetics of DR in yeast has been expertly
reviewed elsewhere54 , so I will present only a brief overview here.
Genetics of increased longevity under mild DR
A mild reduction in glucose concentration in the medium, from 2% to 0.5%,
caused an increase in replicative lifespan via genetic pathway dependent on a shift of
carbon metabolic flux away from anaerobic fermentation and toward aerobic respiration'
(Figure 5). Increased mitochondrial carbon metabolism was inferred from an increase in
oxygen consumption during DR. This respiration increase was necessary for DR to
increase lifespan, because deletion of the cytochrome cl gene cytl suppressed respiration
and prevented the longevity increase. Furthermore, blocking oxidative metabolism of
carbon by deleting a subunit of the pyruvate dehydrogenase complex, latl, prevented DR
longevity, and latl overexpression increased the lifespan of 2% glucose cells but not DR
cells53. Reduced glycolysis and increased respiration during DR raises the cellular
NAD+/NADH ratio, and this elevated ratio is necessary and sufficient to increase
longevity55. The change in NAD+/NADH ratio produced by altered glucose metabolism
during mild DR activates the lifespan-regulating NAD-dependent deacteylase SIR2 and
its homologues, which drive increased lifespan'. Deletion of all the sir2 homologues
suppresses DR longevity under mild glucose restriction in the hands of most
investigators53' 56, though there has been one reported exception57
Genetics of increased longevity under severe DR
More recently, it has been reported that a severe limitation of glucose, to 0.05%,
produces a robust extension in yeast replicative lifespan mediated by a genetic pathway
that apparently requires neither the electron transport chain nor any sirtuin
homologues 51',52. The genetic determinants of this pathway are not well understood at this
time, but a role for the Akt homologue sch9 or the Tor homologue torl has been
suggested, because deletion of either of these genes produces a striking lifespan increase
that cannot be further extended by 0.05% glucose51
The interpretation of the sir2- and respiration-independent lifespan increase under
extreme glucose limitation has been a matter of some debate recently, with two
possibilities being proposed 52, 58. First, subtle sir2-independent lifespan increases might
have been originally masked by suboptimal DR conditions at 0.5% glucose; alternately,
mild and severe DR conditions might induce separate longevity pathways. I favor the
second interpretation for a number of reasons. First, numerous experiments from different
laboratories have repeatedly confirmed that deletion of sir2 and its homologues prevent
lifespan extension by 0.5% glucose, though not 0.05% glucose53' 56. Second, the
physiological responses of yeast to 0.5% and 0.05% glucose differ, with growth and cell
cycle being minimally affected by 0.5% glucose, but severely slowed by 0.05%
glucose59. It is therefore reasonable to suppose that responses that limit protein synthesis
and increase autophagy, such as reduction of torl activity, would be engaged in 0.05%
glucose, but not 0.5%. Third, the NAD+/NADH ratio is strongly increased in cells under
0.5% glucose, but much less so in cells under 0.05% glucose, suggesting a different
metabolic response to the two conditions53 . Fourth, mutations that block DR longevity at
0.5%, such as cytlA and sir2A, actually have the opposite effect at 0.05% glucose,
instead enhancing the longevity response53, 60. This observation suggests that the 0.5%-
response genes inhibit the 0.05%-response genes, allowing the cell to fine-tune its
responses to various levels of nutrient availability (Figure 5). Notably, mutations that
extend replicative lifespan at 0.05% glucose also generally increase the chronological
lifespan of stationary phase cells that lack nutrients entirely, while genes extending
replicative lifespan at 0.5% glucose generally do not 61, 62. This observation supports the
view that genes such as sch9 and torl become increasingly important in lifespan control
as food restriction becomes more extreme, while genes such as sir2 decrease in
importance.
Interestingly, both 0.5% glucose and 0.05% glucose increase lifespan by a
mechanism dependent on the pyruvate dehydrogenase subunit lat153. Undoubtedly,
future work will uncover many more cross-regulations between longevity pathways
responding to different degrees of food limitation.
Genetic mimics ofDR
In addition to physical limitation of available glucose, several mutations affecting
glucose transporting or sensing genes have been shown to extend lifespan in yeast. These
include the cdc25-10 mutation that disrupts a glucose-sensing GTP/GDP exchange factor,
Hap4 overexpression that increases respiration, and deletion of the hexokinase hxk2,
which prevents glucose entry into glycolysis 5s. As mentioned above, mutation of the Akt
homolog sch9 has also been suggested to be a mimic of DR51 . Interestingly, these "DR
mimic" mutations can be divided into two classes based on genetic epistasis, and this also
supports the view that there is more than one genetic pathway controlling nutrient-
dependent lifespan. The first class of mutations, including the cdc25-10 mutant and Hap4
overexpressor, appear to share characteristics with the response to 0.5% glucose: like
0.5% glucose, cdc25-10 and Hap4 overexpression required sir2 and latl to increase
lifespan 53 . hxk2A and sch9A fall into a separate class of nutrient-responsive longevity
genes, their effects on lifespan being independent of sir2 and lat153. Presumably at least
one additional class of nutrient-responsive genes exists which, like 0.05% glucose, have
longevity effects that are independent of sir2 but dependent on lat153.
A role for the hypothalamus in DR?
It will be apparent from the preceding discussion that considerable parallels exist
between the genetic pathways in yeast that translate low glucose perception into long
lifespan and the genetic pathways in the hypothalamus that translate perception of low
energy availability into appropriate efferent signals (Table 1). Glucose sensing in both
yeast and hypothalamic neurons is coupled to glucose metabolism in similar ways. Both
cell types depend on a hexokinase enzyme to detect glucose, and use elevated NADH as a
signal of high glucose. Increased respiration is a critical step in sensing low nutrients in
both yeast and AgRP neurons. In addition, torl/TOR, snfl/AMPK, and sch9/Akt
homologues play a role in both nutrient-sensitive longevity in yeast and nutrient sensing
in the hypothalamus. It is not known whether malonyl-CoA/LCFA levels affect lifespan
in yeast, but yeast do contain homologues of all the essential mammalian components of
this biochemical pathway. The apparent similarities between pathways that sense
nutrients and affect DR longevity in yeast and pathways that sense nutrients in the
hypothalamus beg the question: is DR longevity in mammals mediated by afferent
hypothalamic signaling?
Answering this question would require perturbing the hypothalamus in some way
and then demonstrating insensitivity to DR in the manipulated animal. To my knowledge,
an experiment of this type has not yet been performed in a mammal. However, there is
excellent evidence that the mammalian hypothalamus can control longevity, in addition
to its well-established role in energy balance. For some years, a role of the hypothalamus
in mammalian lifespan control has been indirectly inferred from the critical role of the
pituitary in mammalian aging. The pituitary is a master endocrine gland that is chiefly
controlled by hypothalamic input, both by direct innervation and by short-range hormonal
signals relayed by a portal vein system. Removal of the pituitary (hypophysectomy) can
extend lifespan63, 64 , though it is not known whether hypophysectomy increases lifespan
by the same mechanism as DR. Testing the DR response in hypophysectomized animals
is somewhat confounded by the fact that these animals exhibit lower voluntary food
intake, possibly imposing DR on themselves 64. Apart from surgical removal of the
pituitary, any of several mutations that reduce growth hormone release, or its reception in
peripheral tissues, also extend lifespan 65-67. These mutations appear to have effects quite
distinct from those of hypophysectomy, as they induce hyperphagia and age-dependent
obesity68. This reduced growth hormone longevity pathway is though to act by a separate
mechanism than DR 68 . This conclusion is partly based on the finding that long-lived
mutants with reduced growth hormone secretion live even longer when subjected to
DR69
Another indirect indication that the hypothalamus may control mammalian aging
comes from a fat-specific knockout of the murine insulin receptor. This mutation caused
a dramatic reduction in fat mass and plasma leptin level, promoting hyperphagia
mediated by the hypothalamus, and also caused a significant lifespan extension 70 . It
remains untested whether the hypothalamus is involved in the lifespan increase.
However, DR and fat-specific insulin receptor knockout produce similar alterations in fat
mass, leptin level, appetite and metabolism, suggesting possible commonalities in
mechanism.
Recently, an exciting direct connection between nutrient-sensitive cells of the
hypothalamus and mammalian longevity was demonstrated by Conti and colleagues71.
UCP2 was overexpressed specifically in the orexigenic hypocretin neurons in the lateral
hypothalamus of mice. The intent of this manipulation was to cause thermogenesis in the
hypocretin neurons and thus raise the temperature of nearby temperature-sensitive centers
of the hypothalamus, causing lowered core body temperature, all of which did, in fact,
occur. However, overexpression of UCP2 would also be predicted to increase hunger
perception in the hypocretin neurons. (Although it is not known whether hypocretin
neurons normally elevate UCP2 expression as a signal of hunger, as the AgRP neurons
do, increased mitochondrial uncoupling would be expected to induce a low energy state
in any cell due to reduced efficiency of ATP production.) Consistent with this prediction,
these mice showed mild hyperphagia: despite their reduced daily calorie requirement due
to reduced core body temperature, transgenic mice ate as much food as wild-type controls
and males gradually became obese as they aged. Remarkably, the UCP2-overexpressing
mice also had longer mean and maximum lifespan than controls, by 12% in males and
20% in females. Thus, altered gene expression in a single population of hypothalamic
neurons is sufficient to modify energy balance and increase lifespan. It remains to be
tested whether the hypocretin neurons play a role in DR longevity, but Conti and
colleagues do note that the change in lifetime mortality of the long-lived transgenic mice
resembles that observed when Drosophila is diet-restricted, and differs from that
observed when Drosophila is raised at lowered temperature. This is consistent with the
idea that hypocretin neurons and dietary restriction affect aging by the same mechanism.
If increased hypocretin neuron activity could be shown to extend lifespan by the same
mechanism as DR, this would suggest that the DR longevity pathway is separable from
the low adiposity of DR animals, since the UCP2 overexpressors are obese. This would
raise the intriguing possibility that the influence of DR on lifespan is not a mere passive
consequence of altered peripheral metabolism, but a separate, active response coupled to
nutrient sensing, as is the case in yeast.
Neural regulation of DR longevity in invertebrates
Several reports in the last few years have established that the nervous system is a
critical regulator of invertebrate lifespan. In C. elegans, loss of chemosensory ability in
all neurons dramatically extends lifespan s5, as does laser ablation of specific neurons 72,
and in Drosophila, ablation of specific insulin-producing neurons in the head is sufficient
to extend lifespan 73. Strong evidence for a critical role of neurons in mediating the DR
longevity response of metazoans has recently been obtained from two invertebrate
studies, one in flies and one in worms.
The fly study74 reported two important findings. First, the authors showed that the
odor of food alone was sufficient to reduce the longevity response of dietary-restricted
flies, suggesting that odor-sensitive neuronal pathways modulate DR longevity. Second,
this study showed that mutation of a pan-neuronally expressed chemoreceptor called
Or83b disrupted the function of many sensory neurons and extended lifespan
significantly. These long-lived mutant flies responded less robustly to DR than the wild
type, suggesting that the lifespan extension mediated by these neurons might overlap
mechanistically with DR longevity. Interestingly, it was shown in a separate study that
neuron-specific overexpression of human UCP2 in flies extended lifespan75. The
interaction of this lifespan extension with DR was not examined, but given the
importance of UCP2 in hypothalamic nutrient sensing and possibly lifespan control, it is
tempting to speculate that this neuronal UCP2 overexpression may have driven the fly
nervous system to perceive hunger and activated concomitant DR-like lifespan extension
pathways. Consistent with this interpretation, an endogenous Drosophila uncoupling
protein, dUCP5, is required specifically in neurons to mediate normal adaptation to low
energy conditions 76, suggesting that the neuronal uncoupling-dependent mechanism of
mammalian energy sensing is conserved in flies.
The second recent study to implicate neurons in the control of DR longevity is
described in the remainder of this thesis. A brief summary follows. A pair of sensory
neuroendocrine cells in the worm head, called the ASI neurons, are in many ways
functionally analogous to the hypothalamus. The ASI neurons sense food in the
environment and integrate this information with intrinsic energy availability to modulate
hormonal signaling that controls dauer entry in larvae and fat metabolism in adults77-79. In
Chapter 2, I show that a transcription factor called skn-1 is required to act specifically in
the ASI neurons in order for worms to increase lifespan in response to DR. Furthermore,
ablation of the ASI neurons prevents the DR longevity response. This and other studies
show that, as in yeast, DR causes increased respiration in worms22 ,80. This respiration
increase is also mediated by skn-1 activity in the ASI neurons, suggesting that metabolic
changes in peripheral tissues induced by DR are dependent on cell-nonautonomous
signaling from the ASIs.
Taken together, the recent evidence linking energy-sensitive neurons to lifespan
control suggests a model in which DR produces longevity by a mechanism very similar to
that of yeast, except that the effectors of metazoan DR longevity are cell-nonautonomous
(Figure 6). Many of the mechanisms by which yeast senses nutrient deprivation are
conserved in the mammalian hypothalamus. However, where the unicellular yeast
induces longevity effectors in the same cell, the hypothalamus likely induces cell-
nonautonmous signals that induce effectors of metabolic changes and longevity in
peripheral tissues.
Other nutrient-sensitive genes that regulate invertebrate lifespan
Many of the homologues of genes known to regulate DR longevity in yeast and/or
nutrient sensing in the hypothalamus have also been shown to regulate lifespan in worms
and/or flies (Table 1). Some of these have been suggested to function by the same
mechanism as DR. Almost none have yet been tested for a neural basis of action.
The daf-2 insulin receptor homolog in C. elegans was one of the first genes
shown to control metazoan lifespan81. Mutation of daf-2 extends lifespan by reducing
activation of homologues of PI3K and Akt, causing dephosphorylation and nuclearization
of daf-16, a worm Forkhead homolog82 (Figure la). daf-2 functions at least partly in
neurons to regulate lifespan 83,84. Because daf-16 mutation completely suppresses the
longevity of well-fed daf-2 mutants81, whereas DR produces a normal lifespan extension
in daf-16 mutants20,'85 (see Chapter 2), it has been argued that DR longevity is
independent of insulin signaling in worms. However, several groups have observed
significantly greater lifespan extension by DR in daf-2 animals compared to the wild type
(ref. 85 and Chapter 2), suggesting that insulin signaling may in fact antagonize DR
longevity by a daf-16-independent mechanism. The control of lifespan by insulin
signaling is conserved in flies and mammals 82 . It has been argued that reduced insulin
signaling and DR increase lifespan by a common mechanism in flies86, though the
interpretation of this data has been disputed87 . Further work is clearly needed to clarify
the influence of neural insulin signaling on the lifespan of well-fed and diet-restricted
metazoans.
Reduced TOR signaling can extend lifespan in yeast51 , worms88, and flies89 .
This conservation across taxa strongly suggests TOR will also prove to regulate
mammalian lifespan. Dietary restriction is unable to further extend the lifespan of yeast,
worms, or flies with reduced TOR signaling5 1' 89,90, suggesting a common mechanism of
action of these two interventions. An assessment of the possible neural basis of TOR
effects on lifespan and the interaction of neural TOR activity with DR lifespan extension
is required.
Another energy-sensitive kinase, AMPK, has been shown to extend lifespan when
hyperactivated in worms91. The relevant tissue(s) of action are not known. Surprisingly,
deletion of a worm AMPK a-subunit, aak-2, did not affect dietary restriction-induced
longevity92 (and my unpublished observations), though this may be due to redundancy
with another a-subunit in the worm genome.
Finally, homologues of the first DR effector gene ever identified, yeast sir2, have
been shown to play roles in DR in other organisms. In flies, dSir2 is required for DR to
extend lifespan9 3; the tissue(s) in which dSir2 acts during DR is not known. Interestingly,
though, a neural activity mediated by a sirtuin during mammalian DR has been suggested
by a study showing that Sirtl, the nearest mammalian homologue of yeast sir2, is
specifically required for the increase in spontaneous movement typically observed in DR
animals 94. Sir2 genes have not thus far been convincingly connected with DR in worms;
however, only one of the four worm sir2 homologues has been tested to date 90
Conclusions and future directions
We stand on the edge of a mechanistic understanding of how dietary restriction
extends lifespan. The latest results from invertebrates indicate that energy-sensing
neurons play a critical role in the control of DR-induced longevity, but the critical
experiments have not yet been done to determine whether similar mechanisms function in
mammals. At present, we have a strong understanding of how energy-sensing pathways
function in the mammalian brain and an extensive catalogue of genes that regulate aging
in invertebrates. As has been described in this chapter, considerable overlap between
these two categories exists, but in most cases, it is not known whether the longevity
mutants function in the same genetic pathway as DR, nor whether they function in
neurons. DR interaction studies of the type that have been described86 are needed in
invertebrate longevity mutants to determine whether the mutant genes mediate DR. For
genes that act in the DR longevity pathway, tissue specificity should be determined to
identify possible neuronal roles. As a first step in evaluating the importance of the
hypothalamus in DR longevity in mammals, the DR longevity response should be tested
in hypophysectomized animals or in mutant animals with defective hypothalamic energy
sensing.
If mammalian hypothalamic energy sensing is convincingly linked to DR
longevity by future studies, one of the more exciting possibilities that should be explored
is the question of whether the DR longevity response is separable from the other
hypothalamic outputs caused by perception of low energy balance, such as reduced
peripheral metabolic rate, feelings of hunger, and impaired reproduction. This is
important for potential future medical activation of putative hypothalamic DR longevity
pathways, as few patients are likely to tolerate concomitant obesity, hunger, and sterility.
Excitingly, there is preliminary evidence that the longevity effects of DR can, in fact, be
uncoupled from metabolic effects. Dietary restriction of genetically obese ob/ob mice
results in an extended lifespan equal to that of diet-restricted wild-type, even though the
ob/ob mice retain greater adiposity than AL wild-type 95. Thus, the effects of DR on
lifespan can be uncoupled from low adiposity. Separability of different hypothalamic
outputs during DR is further suggested by the study showing that Sirtl KO mice have a
specific defect in the increased spontaneous movement response to DR, whereas many
other physiological parameters change normally94. It will be interesting to see whether
future experiments reveal general separability of distinct hypothalamic outputs during
DR, particularly the putative longevity signals. Eventual development of specific
activators of DR longevity pathways holds the promise of therapeutic panaceas against
hosts of age-related diseases, and perhaps increased healthy lifespan for all of
humankind.
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Table 1. Conserved control of energy sensing, lifespan, and DR longevity response.
Gene or metabolic Energy sensing Lifespan control DR longevity
process
Y W F M Y W F M Y WF M
NADH level /
neuronal signaling na na / / na
PI3K
FoxO1 na / / / na / na x
AMPK " , I , / ? x
Y= yeast, W = worm, F = fly, M = mammal. "/" symbol indicates that a given gene or process is
connected with the energy sensing, lifespan control, or DR longevity in the corresponding model organism.
"x" symbol indicates that there is evidence that the given gene or process is not involved in DR longevity
in the corresponding model organism. na = not applicable. Blank table cells indicate that a potential
interaction has not been tested.

Figure 1. Some lifespan control pathways that are conserved in multiple species.
(a) Insulin-like signaling accelerates aging. Yeast lack the insulin receptor, but retain
downstream kinases such as the Akt homologue sch9. Abbreviations: GH, growth
hormone; ILPs, insulin-like peptides; IGF-1 insulin-like growth factor 1.
(b) TOR signaling accelerates aging. AMPK activation slows aging, and may do so in
part by inhibiting TOR signaling. aak-2 is a homologue of the mammalian AMPK
catalytic a subunit.
(c) Dietary restriction extends lifespan in all species shown. The lifespan extension
depends on SIR2 in flies. Yeast DR longevity depends on sir2 and/or related sirtuins
under some circumstances (see text). Some physiological responses to DR depend on
sirtuins in mammals, though a role in DR longevity for sirtuins remains to be tested.
Sirtuins have not been linked to DR in worms, but do regulate lifespan.
(d) Small subsets of neurons can control lifespan in worms, flies, and mammals.
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Figure 2. Homeostatic energy balance is maintained by the hypothalamus.
(a) Afferent signals, such as nutrient availability, energy status-dependent hormones from
the periphery, and signals from sensory and reward centers of the brain are integrated by
the hypothalamus and translated into nervous and hormonal outputs that modulate
multiple physiological and behavioral processes.
(b) Principal hypothalamic nuclei modulating feeding and peripheral energy expenditure.
Nuclei and pathways are color-coded according to whether they are orexigenic (green) or
anorexigenic (blue). Nutrients, and the nutrient-dependent hormones leptin and insulin,
activate anorexigenic POMC neurons and inhibit orexigenic AgRP neurons in the arcuate
nucleus. When activated, POMC neurons secrete a-MSH, a proteolytic cleavage product
of POMC, which is an agonist of the MC4R on anorexic neurons in the paraventricular
and ventromedial hypothalamus. Activated AgRP neurons secrete AgRP, which
antagonizes the MC4R. Orexigenic MCH and hypocretin (Hcrt) neurons in the lateral
hypothalamus regulate energy balance in parallel to the MC4R neurons. Abbreviations:
POMC: proopiomelanocortin; AgRP: agouti-related peptide; a-MSH: alpha-melanocyte
stimulating hormone; MC4R: melanocortin-4 receptor; MCH: melanin-concentrating
hormone.
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Figure 3. Intracellular energy sensing mechanisms in hypothalamic neurons.
(a) Glucose-excited hypothalamic neurons sense glucose by a mechanism similar to that
used by pancreatic p-cells. The pancreatic form of glucokinase (GK) drives glucose entry
into the glycolytic pathway. Glycolysis elevates cytosolic NADH and pyruvate. Shuttling
of cytoplasmic NADH into the mitochondria is essential for subsequent electron transport
chain (ETC)-dependent production of ATP. Increased ATP closes ATP-sensitive
potassium channels, leading to neuronal activation.
(b) Additional intracellular energy sensing mechanisms responding to fat, ATP, glucose,
and amino acids. In high energy conditions, intracellular long-chain fatty acid acyl-CoA
(LCFA-CoA) levels in hypothalamic neurons are high, which causes anorexigenic
responses. The LCFA-CoA level is increased by synthesis from LCFAs (by acyl CoA
synthase, ACS). Also, malonyl-CoA is synthesized from glucose-derived acetyl-CoA by
acetyl-CoA carboxylase (ACC). Malonyl-CoA increases LCFA-CoA levels by inhibiting
their transport into the mitochondria (via inhibition of carnitine-palmitoyl transferase,
CPT1), thus preventing LCFA 3-oxidation. Malonyl-CoA also increases LCFA-CoA
levels by direct contribution to synthesis, via fatty acid synthase (FAS). AMPK inhibits
ACC, and is itself inhibited by high ATP. mTOR inhibits feeding, possibly in response
to high amino acids.
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Figure 4. Interaction between leptin- and insulin-dependent neuropeptide
regulatory pathways in POMC and AgRP neurons.
In both types of neurons, leptin binding to its receptor (LepR) causes phosphorylation of
Stat3, which binds to the neuropeptide promoter. Insulin binding to its receptor activates
PI3 kinase, which activates Akt/PKB, which phosphorylates FoxO 1 and causes its
exclusion from the nucleus. Leptin binding may also activate PI3K. Stat3 and FoxO1
bind to partially overlapping sites on the neuropeptide promoters, such that prior binding
of one precludes the binding of the other. Stat3 activates POMC and inhibits AgRP,
whereas FoxOl inhibits POMC and activates AgRP. Thus, high leptin upregulates
POMC and represses AgRP; high insulin derepresses POMC and downregulates AgRP.
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Figure 5. Different longevity pathways predominate at mild vs. extreme DR in yeast.
Yeast is normally cultured with 2% glucose in the medium. At mild (0.5%) glucose
restriction, the longevity pathway on the left side of the figure is most important.
Reduced glycolysis leads to lower cytoplasmic NADH. Carbon flux through the pyruvate
dehydrogenase complex (PDC), especially its subunit latl, is increased under 0.5%
glucose, which elevates mitochondrial respiration and further lowers NADH. The
elevated NAD+/NADH ratio increases activity of sir2 and/or the related genes hstl and
hst2, which increases lifespan. At severe glucose restriction (0.05% glucose), an
apparently separate longevity pathway predominates, which extends lifespan without
requiring any of the genes in the 0.5% glucose longevity pathway except latl. sch9 and
torl inhibit lifespan, acting by the same mechanism as 0.05% glucose and downstream of
or in parallel to latl. The 0.5% glucose longevity pathway appears to antagonize the
0.05% longevity pathway, as 0.05% glucose extends lifespan much more effectively in
strains bearing deletions in the three sirtuin genes or genes required for function of the
electron transport chain.
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Figure 6. Model of potentially parallel mechanisms of DR longevity control in yeast
and metazoans.
Both model systems sense external nutritional cues, in yeast via the glucose-sensitive
GPCR gpal, and in metazoans via sensory neurons. Both model systems integrate this
environmental information with cellular energy status, sensed by similar pathways in
both yeast and metazoan. Glucose is sensed in both models by a mechanism depending
on hexokinases to drive glucose metabolism and on elevated NADH and mitochondrial
activity. Nutrients are sensed and lifespan controlled by homologues of Akt, TOR, and
AMPK in both systems. Sirtuins are involved in some responses to DR in both model
systems. Long chain fatty acids are important in mammalian hypothalamic energy
sensing, but their importance is not known in yeast. The primary difference between
yeast and metazoan DR longevity control is that, in yeast, cellular energy-sensing
pathways are coupled directly to cellular energy homeostasis and lifespan effectors, while
in metazoans, cellular energy-sensing pathways are coupled to cell-nonautonomous
signaling that achieves organismal energy homeostasis and lifespan control. A necessary
consequence of this difference is that metazoan energy-sensing neurons receive
additional afferent inputs from the periphery that are indicative of organismal energy
status.

FIGURE 6
Yeast
external glucose
sensing (e.g., gpa l)
Yeast Mother Cell
energy
balance, lifespan
Metazoans
sensory
neurons
afferent
hormonal
signals
V
energy lifespan
balance

CHAPTER 2
skn-1 Acts in Two Neurons to Mediate Dietary Restriction-Induced
Longevity in C. elegans
This chapter is in press at Nature. The authors are Nicholas A. Bishop and Leonard
Guarente.

Summary Paragraph
Dietary restriction (DR) extends lifespan and retards age-related disease in many
species' and profoundly alters endocrine function in mammals 2. However, no causal role
of any hormonal signal in diet-restricted longevity has been demonstrated. Here we show
that increased longevity of diet-restricted C. elegans requires the transcription factor skn-
1 acting in the ASIs, a pair of neurons in the head. DR activates skn-1 in the ASIs,
thereby signalling peripheral tissues to increase metabolic activity. These findings
demonstrate that increased lifespan in a diet-restricted metazoan depends on cell-
nonautonomous signaling from central neuronal cells to non-neuronal body tissues, and
suggest that the ASIs mediate dietary restriction-induced longevity by an endocrine
mechanism.
Results and Discussion
Dietary restriction extends lifespan in many organisms and reduces incidence and
progression of age-related disease1. In mammals, DR dramatically alters central and
secondary hormone production and target tissue responsiveness, suggesting a mechanism
by which this regimen coordinately slows aging across a variety of tissues2. A possible
hormonal link of DR to longevity is suggested by the recent demonstration that serum
from DR mice contains factors sufficient to induce many of the cellular phenotypes of
DR in vitro3 . However, no hormone has been shown to mediate DR longevity in vivo, and
indeed mice that almost completely lack several pituitary hormones respond normally to
DR4, so the question of whether DR induces longevity by an endocrine mechanism
remains unresolved.
DR has been shown to extend lifespan in the roundworm C. elegans5 . We
developed a DR protocol that reliably increases longevity in worms (see Methods; Fig.
la). Worms cultured on standard plates seeded with the bacterial food source throughout
larval development were then transferred to a small volume of liquid medium in which
bacterial density was controlled at a range of different levels (see Methods). Worms
maintained at high bacterial density (our ad libitum, or AL, condition) had a slightly
longer lifespan than worms cultured on agar plates seeded with a bacterial lawn (Fig. la).
Mean lifespan increased as bacterial density was reduced until a maximum lifespan was
reached at an optimal dilution of 1:10 (our DR condition), while further dilutions caused
reduced mean lifespan, presumably due to starvation (Fig. lb). DR animals also exhibited
reduced fat in the intestine and small body size (Supplementary Fig. S la-b). Animals in
the AL condition exhibited an optimal brood size, while DR animals had a reduced brood
size and extended reproductive period (Supplementary Fig. S c). As reported for other
methods of DR6' 7, this DR protocol extended the lifespan of both daf-16 and daf-2
mutants (Figure 1 c), which function in the well-characterized insulin-like signaling
pathway 8. Here, we describe the use of this protocol to identify a gene mediating DR
longevity: skn-1.
skn-1 has previously been shown to be critical in endodermal development 9 and
control of the oxidative stress response1 o, functions that are shared by the most similar
mammalian proteins, the NF-E2-related transcription factors. Since oxidative damage is
thought to be a key cause of aging I, it has been proposed that skn-1 may be a
determinant of aging rate1o. Notably, some isoforms of skn-1 are expressed in an operon
downstream of bec-1, the C. elegans homolog of mammalian beclin 1. Beclin 1 mediates
autophagy induced by nutrient deprivation 12, suggesting that skn-1 might be regulated in
response to nutritional stress (Fig. 2a). We therefore tested whether skn-1 functions in the
DR-induced longevity response. Four loss-of-function alleles of skn-1 all significantly
impaired response to DR (Fig. 2b; Supplementary Fig. S2a and S3). Skn-1 mutant
lifespan was unresponsive to diet over a wide range of food concentrations (Fig lb). skn-
1 mutations appeared to specifically interfere with the DR longevity response, as they did
not impair the longevity increase caused by mutation of daf-2 (Supplementary Fig. S4) or
by treatment with a plant polyphenol extract"3 . We focused our subsequent analysis on
two alleles, skn-1(zul35) and skn-1(zu169), because they prevented the longevity
increase on DR completely, yet had little or no effect on AL lifespan (Fig. 2b). These two
alleles introduce premature stop codons before the sequence encoding the DNA-binding
domain of all skn-1 isoforms (Supplementary Fig S2a; also see below). The failure of
both skn-1 mutants to respond to DR was rescued by Is007, an integrated transgene
expressing a skn-1::gfp fusion from its native promoter10 (Fig. 2a and 2c; Supplementary
Fig. S2a), confirming that these skn-1 mutations caused the DR longevity defect.
The rescuing Is007 transgene is expressed in only two tissues: in the two ASI
neurons, and in the intestine10 . This is an intriguing expression pattern in the context of
DR, since the intestine is the food absorption and storage organ, and the ASIs are sensory
neurons in the head that are critical in translating information about food availability into
endocrine signals that influence the dauer decision during development1 4 . We asked in
which tissue skn-1 acts to mediate DR longevity. The skn-1 gene encodes three protein
isoforms, SKN-lA, SKN-1B, and SKN-1C, which have different N-termini but a
common C-terminus (Fig. 2a). Using 5' RACE, we obtained evidence that each of these
isoforms is expressed from an independent promoter (Supplementary Fig. S2b-d).
Because most of the unique 5' coding region of skn-la is not included in the rescuing
Is007 transgene (Fig. 2a), we reasoned that skn-lb and/or skn-lc must be sufficient to
rescue DR in the skn-1 mutants. We used RNAi feeding clones corresponding to the
unique 5' end of either skn-lb or skn-lc to knock down each isoform separately in GFP
reporter strains, and determined that skn-lb is expressed in the ASI neurons but not
detectably in the gut, and skn-lc is expressed in the gut but not detectably in the ASI
neurons (Fig. 2d-f). An extrachromosomal transgene that drives skn-lb::gfp expression
from the ASI-specific gpa-4 promoter 15 showed expression in the ASI neurons, but not
the gut, and rescued the DR longevity defects of skn-1(zu135) animals completely (Fig.
2g). Similar results were obtained with the same transgene in a skn-l(zul69) background,
and also with a chromosomally integrated version of the transgene (Supplementary Table
S 1). In contrast, extrachomosomal and integrated transgenes driving skn-lc::gfp from the
ges-1 promoter 16 showed expression only in the gut, and had no effect on the DR defect
of skn-1(zul35) (Fig. 2h). Furthermore, ectopic expression of skn-lc::gfp in the ASI
neurons using the gpa-4 promoter failed to rescue the DR longevity defect of skn-
1(zu135) (Supplementary Table Si). Taken together, these data indicate that skn-lb
functions in the ASI neurons to mediate DR longevity.
To confirm that the ASI neurons are required for DR-induced longevity, we used
a laser microbeam to specifically kill these two cells and tested the effect in subsequent
DR. Ablation of the ASI neurons completely suppressed the response to DR (Fig. 3a), but
also caused a small increase in basal longevity, consistently with a previous report"7. The
ASIs can apparently affect lifespan by two independent pathways, since the increase in
basal longevity was previously reported to be dependent on daf-1617, and DR longevity is
not (Fig. Ic). We reasoned that the use of a daf-16 mutant would separate the two effects
of ablating the ASI neurons and allow us to determine their role in DR longevity
specifically. As expected, when we repeated the ASI ablation in daf-16 animals, we
found that basal longevity was unaffected by the ablation (Fig. 3b). Importantly, DR
longevity was still suppressed (Fig. 3b). These results support the model that skn-1
functions in the ASI neurons to extend lifespan in response to DR.
We next investigated how skn-1 acts in the ASI to mediate DR longevity. To rule
out the possibility that skn-1 mutation disrupts development of the ASI neurons, we used
a panel of ASI-specific GFP reporters to confirm that the ASI neurons exhibit normal
morphology and cell fate in a skn-1 background (Supplementary Fig. S5). We then tested
whether SKN-1::GFP is induced by DR in Is007 animals. Although we saw no specific
induction in the intestine (data not shown), DR significantly increased SKN-1::GFP
fluorescence in the ASI neurons (Fig. 4a). The fluorescence increase was specific to
SKN-1::GFP expressed from its native promoter, because if the protein was expressed
from the ASI-specific gpa-4 promoter, we observed instead a slight decrease in
expression during DR (Fig. 4a). This dependence of skn-1 induction on the native
promoter suggests that skn-1 may be transcriptionally regulated during DR.
In yeast, DR induces an increase in respiratory rate' , and there is evidence that
this is also the case in worms 9',20. We measured the whole-body oxygen consumption rate
of large populations of wild-type worms on day 3 of AL and DR (see Methods), and
found that DR worms exhibited elevated respiration (Fig. 4b). The respiration rate
increase on DR was absent in a skn-1(zu135) mutant, but could be rescued, and somewhat
enhanced, by the Is007 transgene (Fig. 4b), demonstrating that skn-1 is necessary for the
increased respiration. The increase in respiration is likely to be necessary for the DR
longevity effect, because two different specific inhibitors of the mitochondrial electron
transport chain (ETC) complex III, myxothiazol and antimycin, suppressed DR longevity
without shortening AL lifespan (Fig. 4c-d). Further, myxothiazol completely suppressed
the increase in respiration under DR (data not shown). The effect of inhibiting electron
transport was specific to DR longevity, as the long life of a daf-2 mutant was not affected
by antimycin (Fig. 4e). Finally, to determine whether skn-1 in the ASI neurons alone is
sufficient to rescue the absence of increased respiration in the skn-1(zul35) mutant during
DR, we constructed two stably integrated transgenes: gels9, which drives skn-1b::gfp
expression in the ASI neurons, and gelsl0, which drives skn-lc::gfp expression in the
intestine. gels9 expressed strongly in the ASIs, and also rescued and enhanced the
respiration response to DR in the skn-1(zul35) mutant (Fig 4b). The gels9 line sometimes
showed weak expression in a few cells apart from the ASIs, though these are unlikely to
contribute to the observed rescue (see Methods and Supplementary Fig. S6). gelsl0O, in
contrast, failed to rescue the DR respiration defect of skn-1(zu135), despite expressing
efficiently in the intestine (Supplementary Fig. S6). These findings suggest that DR-
induced activation of skn-1 in the ASIs causes release of a signal that promotes
metabolism in peripheral tissues and leads to long life. Interestingly, it appears that skn-1
has two functions in the adult that are separable by isoform and tissue of expression:
mediation of DR longevity by skn-lb in the ASI neurons, and resistance to oxidative
stress by skn-lc in the intestine (Supplementary Fig. S6).
How might DR activate skn-1 in the ASIs? Although the ASI is a sensory
neuron20, sensation of the environment by the ASI is unlikely to be necessary for DR to
increase longevity, because mutants lacking functional sensory cilia still expressed SKN-
1::GFP in the: ASI neurons (not shown) and responded normally to DR (Fig. 4f). It has
recently been shown that, within particular cells of the mammalian hypothalamus, levels
of key intracellular metabolites indicative of energy availability control organismal food
intake and energy metabolism22 . We propose that the ASI neurons similarly detect their
own cellular energy state and adjust the animal's overall metabolism in response to
nutrient availability. Because increased expression of skn-l::gfp in the ASI is not
sufficient by itself to extend AL lifespan or to enhance the response to DR
(Supplementary Table 1), other pathways or neurons must act in parallel to skn-1 to
orchestrate DR longevity.
Here we demonstrate that cell-nonautonomous signals from central
neuroendocrine cells to the periphery can mediate DR longevity in a metazoan. The ASIs
have well-established endocrine functions, and express at least 15 known or potential
hormones, including members of the insulin, TGF-P, and neuropeptide classes 23, 24. We
suggest that the ASIs release a hormonal signal upon sensing DR that promotes metabolic
activity in the periphery and leads to increased respiration and long life. We anticipate
that future work will dissect the critical central hormones mediating DR longevity of
worms and mammals.
Methods
Strains
We used the following strains: the wild-type N2, EUI skn-l(zu67)/nTl[unc-?(n754);let-
?], EU31 skn-l (zul 35)/ nTl[unc-?(n754);let-?], EU35 skn-l(zul69)/nTl[unc-
?(n754);let-?], EU40 skn-1(zu129)/ nTl[unc- ?(n754);let-?], LG335 skn-
S(zu135)/nTI[qIs51], LG336 skn-l(zu169)/nTl[qls51], LG333 skn-l(zu135);Is007[skn-
1: :gfp], LG326 skn-1(zul69) ;Is007, LG340 skn-1(zul35)/nTl[qls51];Ex(gpa-4p::skn-
lb::gfp) #1, LG341 skn-1(zul69)/nTl[qls51];Ex(gpa-4p::skn-lb::gfp) #2, LG343 skn-
1 (zul35)/nTJ[qIs51];Ex(ges-lp::skn-lc::gfp), LG344 gels8[gpa-4p::skn-1b::gfp],
LG345 gels9[gpa-4p::skn-lb::gfp], LG348 skn-1 (zu135)/nT1[qls51];gels9, LG349
gelsl O[ges-1p::skn-1c::gfp], LG357 skn-1 (zul35)/nTl[qlsS5];gelsl O, CB 1370 daf-
2(e1370), GR1307 daf-16(mgDf50), CX3596 kylsl28[str-3p::gfp], LG347 daf-
16(mgDf50);kyls128, CB 1124 che-3(e1124), PR813 osm-5(p813), LG331 lin-
35(n745);Is007, LG360 skn-1(zul35)/nTl[qls51];kylsl28, FK181 ksls2[daf-7p::gfp],
LG359 skn-1(zul35)/nTl[qls51];ksls2, CX3594 kyls87[srd-lp::gfp], LG363 skn-
1(zu135)/nTl[qIsSl];kyls87, CX3465 ky1s39[sra-6p::gfp], LG367 skn-
1(zul35)/nT1[qIs51];kyls39, LG313 kylsl40[str-2p::gfp], LG361 skn-
1(zu135)/nTl[qIs51];kylsl40, AU10 aglsl[dod-24p::gfp] (a gift of D. Kim and F.
Ausubel), and the Is007[skn-1::gfp] and Ex(gcs-1A2) strains1° .
Transgenic strain construction
Extrachromosomal array-carrying transgenic strains were generated using standard
microinjection methods35, injecting 50 ng/pL each of the transgene plasmid and the co-
injection marker plasmid pRF4. To make the gpa-4p::skn-lb::gfp construct, the last exon
of skn-1 and fused GFP coding sequence was amplified from Is007 genomic DNA, and
the resulting ]product cut with AhdI and NcoI. skn-lb cDNA was generated by RT-PCR
using a 5' primer with a BamHI-site-containing linker and cut with BamHI and AhdI.
These two restriction fragments were trimolecularly ligated into BamHI/NcoI-cut
pPD95.75 to yield pNB117, a promoterless skn-1b::gfp fusion vector. Approximately 2.9
kb upstream of the gpa-4 coding region was amplified from cosmid C04A12 using
primers that added a 5' Sphl site and a 3' BamHI site. This amplicon was digested with
SphI and BarnmHI and ligated into SphI/BamHI cut pNB 117 to yield the gpa-4p::skn-
Sb::gfp transgene plasmid (pNB121). Adult animals carrying this transgene exhibited
GFP fluorescence in the nuclei of the ASI neurons, and nowhere else. In larvae, weak
expression was observed in one other pair of head neuron nuclei, which may be the
AWAs36 . Integrants of the Ex(gpa-4p::skn-lb::gfp) transgenes, called gels8 and gels9,
were isolated independently from a standard y-ray integration screen37, and were
backcrossed three times to N2 prior to analysis. Following integration, nonspecific low-
level GFP expression accumulated in the extreme posterior few gut nuclei of aged adult
animals. It is improbable that this weak intestinal expression accounts for the observed
effects on DR respiration in gels9 for several reasons: 1) the intestinal expression is very
low-level, detectable only in aged adult animals on normal plates and not in our AL or
DR conditions, and limited to only a few posterior cells; 2) skn-lb is not normally present
in the intestine (Fig. 2e-f) and lacks the transactivation domain of the skn-1 isoforms that
are normally present (Fig. 2a), and therefore is not necessarily capable of performing any
normal intestinal function of skn-1; 3) the low level of intestinal skn-lb that is present in
gels9 animals is definitely not capable of rescuing the only intestine-specific function of
skn-1 that we are aware of, arsenate resistance (Supplementary Fig. S6).
To make the ges-1p::skn-1c::gfp construct, a promoterless skn-1c::gfp plasmid,
pNB 120, was first constructed analogously to pNB117 described above. Next,
approximately 2.5 kb upstream of the ges-1 coding region was amplified from cosmid
C29B10 using primers with 5' SphI and 3' KpnI linkers. The amplicon was subcloned
into SphI/KpnI-digested pNB 117 to yield a ges-1p::gfp transcriptional reporter plasmid,
pNB 123. Worms transformed with this plasmid showed robust GFP expression
throughout the gut, and nowhere else. Next, the entirety of skn-1c::gfp was amplified
from pNB 120 using a 5' primer with a KpnI linker. The amplicon was digested with
KpnI and NcoI and ligated into KpnI/NcoI-cut pNB123 to yield the ges-1p::skn-1c::gfp
transgene plasmid. 21 of 30 transgenic animals from the line used in this report exhibited
nuclear GFP fluorescence in the intestine following heat shock for 20 hr at 290 C (this
degree of nuclear localization is comparable to that observed with the Is007 integrant, see
Fig. 2e). No GFP fluorescence was ever observed outside the gut with or without heat
shock. An integrant of the Ex(ges-lp::skn-lc::gfp) transgene, called gelsl0O, was isolated
from a standard y-ray integration screen37, and was backcrossed three times to N2 prior to
analysis.
To make the gpa-4p::skn-lc::gfp construct, pNB 121 [gpa-4p::skn-lb::gfp] and a
cDNA clone of skn-lc that had been amplified with a 5'BamHI linker were cut with
BamHI/SacI and ligated to yield pNB 125.
Dietary restriction protocol
Lifespan assays were performed in the outer four wells of 6-well tissue culture plates,
with each well containing 2.5 ml DR Bottom Medium and 2.5 ml DR Top Medium. DR
Bottom Medium is composed of standard NGM medium25, supplemented with 1 mg/ml
erythromycin to prevent bacterial division, 12.5 [pg/ml 5-fluoro-2'-deoxyuridine to inhibit
progeny hatching, 50 [tg/ml ampicillin, and 1 mM IPTG; DR Top Medium is identical to
DR Bottom Medium, excluding the agar. Erythromycin inhibits prokaryotic protein
synthesis, but is unable to penetrate the outer membrane of mammalian mitochondria3 8 .
We confirmed that C. elegans mitochondria are also apparently insensitive to
erythromycin, because the drug does not affect oxygen consumption rate or the time
required for larval development (data not shown). The bacterial food source used was
HT115(DE3) carrying the empty RNAi feeding vector pPD129.3629, a strain routinely
used as a vector control in RNAi feeding experiments in C. elegans. This strain remained
viable for weeks without dividing in our DR medium. Bacteria were added from a
concentrated stock to the desired concentration, and bacterial concentration in a 1 ml
sample of each well was monitored spectrophotometrically on a rotating basis so that
each well was sampled every fourth day. Additional bacteria were added as necessary to
maintain starting concentration. AL bacterial concentration was approximately 2.5 x 108
cfu/ml, and the optimal DR level was ten-fold lower, at 2.5 x 107 cfu/ml. Worms were
grown to the L4/young adult stage on NGM plates seeded with OP50 bacteria, then
transferred individually into the wells and maintained at 20 0 C with gentle gyrotory
shaking at 80 rpm.
For the progeny production assays, worms cultured as described except that FuDR
was excluded to allow progeny production, and worms were transferred daily to fresh
wells.
For oxygen consumption assays, the method was scaled up to allow mass culture
of animals. The protocol was essentially identical, except that animals were grown in
larger volumes of DR Top Medium in Erlenmeyer flasks, at a density of approximately
20 animals per ml, and DR Bottom Medium was not used.
Lifespan assay
Most lifespans in this report were measured in the liquid medium described above, except
where noted; in these cases lifespans either were done on plates with the same
composition as DR Bottom Medium seeded with 50 pL concentrated bacteria (appx. 5 x
109 cfu/ml), or on standard NGM plates seeded with OP50 bacteria. Regardless of
medium, the lifespan assay was performed by prodding individual animals with a worm
pick every two days to determine when they died. Animals that were lost, or exploded, or
died from internal hatching of progeny were censored at the time of the event, which
allowed their incorporation into the dataset until the time of censorship as described 39
Worms on plates containing erythromycin lived 30 - 40% longer than worms on plates
without the drug; we attribute this to the previously reported lifespan-extending effect of
suppressing bacterial division 40 . Some assays were done in the presence of respiration-
inhibiting agents (Fig. 4c-e). In these cases the DR medium contained 1% DMSO plus 0
RtM, 30 itM, or 60 [tM myxothiazol, or 0.1% ethanol plus 0 RM or 1 [LM antimycin.
Survival curve p-values were calculated by the Mantel-Cox logrank test using
Prism statistical software (Graphpad).
Laser ablation
The strain CX3596 kyls128[str-3p:gfp], which expresses GFP specifically in the ASI
neuron 26, was used to facilitate identification of the ASI. Synchronized Ll animals were
fed on OP50 for 4 - 8 hours to induce robust GFP expression, then mounted on
microsope slides in 50 mM sodium azide anesthetic and ablated using a laser microbeam
as described 27 . Mock-ablated animals were treated identically in parallel, except that they
were not exposed to the laser. Worms were recovered to OP50 plates and grown to the
L4/young adult stage, at which time absence of GFP was taken to indicate successful
ablation. (We confirmed in a separate control experiment that a cohort of ablated animals
lacking GFP also all lacked the ASI itself, and we never observed a GFP-negative animal
in any of the hundreds of mock-ablated controls). Lifespan of successfully ablated
animals and mock-ablated controls was assayed as described above. The kyls128 strain
proved to have a somewhat shorter lifespan than N2, but this was attributable to intrinsic
strain differences and not to the mounting procedure (Supplementary Fig. S7). The
kyls128 strains increased lifespan on DR by a similar percentage as does N2
(Supplementary Fig. S7).
Respiration assay
Mass plate cultures of synchronized worms were obtained by standard techniques and
grown on OP50 plates to the L4 stage, then transferred to Erlenmeyer flasks containing
AL or DR levels of bacteria, as described above. After three days of culture, animals
were collected by centrifugation and washed free of bacteria in S buffer. Respiration rate
was measured at 25 0 C as described 28, using a Clark-type oxygen electrode
(Microelectrodes Inc.). At least three 1 ml samples containing approximately 500 worms
each were measured for each strain and condition in each experiment. The entire sample
was frozen at -800C following the respiration assay. Protein concentration in each sample
was measured as described28, and oxygen consumption rates were normalized to protein
content.
skn-1 mutants are maternal-effect lethal and must be maintained as balanced
heterozygotes. To obtain nearly pure skn-1(zul35) and skn-1(zu135);gels9 populations
for the oxygen assays, we first balanced skn-l(zul35) with the reciprocal translocation
nTl[qls51], which carries a transgene expressing GFP in the pharynx. We then isolated
non-GFP-pharynx, skn-1 homozygous animals from a synchronous L4 population using
the COPAS Biosorter (Union Biometrica) prior to transfer to the AL or DR culture
conditions. This procedure yielded greater than 95% non-GFP-pharynx populations,
which we confirmed to be skn-1 homozygotes by verifying the embryonic lethality of
progeny of samples of sorted worms.
Fluorescence intensity quantification
Fluorescent images were collected at 1000X magnification (Zeiss) from worms subjected
to 5 days of AL or DR as described above. Fluorescence brightness in the ASI was
quantified using NIH ImageJ software.
RNAifeeding
RNAi feeding assays were done as described29. Worms were fed RNAi from L to L4.
The skn-lb(RNAi) construct included the entire first exon ofskn-lb. The skn-lc(RNAi)
construct included the spliced first three exons from a skn-lc cDNA. In Fig. 2d, a lin-
35(n745) mutation in the strain background was used because this mutation sensitizes the
normally refractory ASI neurons to RNAi41.
Rapid amplification of cDNA ends
5' RACE (Invitrogen) was performed on total N2 RNA in accordance with the
manufacturer's instructions, using a primer specific to the unique first exon of skn-lb.
Sudan Black fat staining
Day 3 adults cultured on plates, in AL conditions, and in DR conditions were stained as
described31
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Supplementary Table S1. Lifespan data for main figures.
Strain and condition # deaths/# censored(# trials) mean ± s.e.m p-value vs. AL control
N2 on agar plates with bacterial lawn 218/25(5) 23.7 ± 0.31
N2 in 1.7x10 8 cfu/ml 22/31(1) 25.6 ± 1.00
N2 in 8.5x10 7 cfu/ml 25/27(1) 33.0 ± 0.99
N2 in 5.7x107 cfu/ml 51/1(1) 34.9 + 0.72
N2 in 2.5x106 cfu/ml 20/32(1) 26.3 ± 1.56
N2 in 2.5x10 5 cfu/ml 34/17(1) 23.2 ± 0.85
N2 with no bacteria 37/12(1) 18.1 ± 0.66
skn-1(zul35) in 2.5x106 cfil/ml 51/2(1) 24.2 ± 0.65
skn-l(zul35) in 2.5x105 cfi/ml 51/1(1) 23.0 ± 0.63
daf-2(el370) AL 23/22(1) 39.0 + 2.11
daf-2(e1370) DR 32/21(1) 60.0 ± 2.7 P < 0.0001
daf-16(mg50) AL 51/2(1) 20.7 + 0.80
daf-16(mg50) DR 53/1(1) 28.4 + 0.37 P < 0.0001
skn-1(zu135);Is007 AL 55/1(1) 26.3 ± 0.47
skn-1(zu135);IsOO7 DR 48/8(1) 33.4 ± 0.69 P < 0.0001
skn-1(zul35);Ex(gpa-4p::skn-1b::GFP) line #1 AL 16/0(1) 25.4 ± 0.87
skn-1(zul35);Ex(gpa-4p::skn-1b::GFP) line #1 DR 15/2(1) 31.2 ± 1.22 P= 0.0005
skn-1(z:u135);Ex(gpa-4p::skn-lb::GFP) line #2 AL 42/1(1) 26.0 ± 0.56
skn-l(zu135);Ex(gpa-4p::skn-lb::GFP) line #2 DR 44/1(1) 33.5 + 0.79 P < 0.0001
skn-1(zul35);gels9[gpa-4p::skn-1b::GFP] AL 39/0(1) 24.7 ± 0.65
skn-l(zul35);gels9[gpa-4p::skn-1b::GFP] DR 55/1(1) 34.6 ± 0.69 P < 0.0001
skn-1(zu169) AL 127/3(3) 24.3 ± 0.39
skn-1(zul69) DR 150/0(3) 25.6 ± 0.46 P = 0.0062
skn-1(zu169);Is007 AL 54/0(1) 25.9 ± 0.52
skn-1(zu169);Is007 DR 61/1(0) 33.4 ± 0.60 P < 0.0001
skn-1(zu169);Ex(gpa-4p::skn-1b::GFP) ALa  10/1(1) 23.5 ± 1.22
skn-1(zu169);Ex(gpa-4p::skn-lb::GFP) DR" 10/0(1) 33.2 ± 1.98 P = 0.0006
skn-1(zu135);Ex(ges-1p::skn-1c::GFP) AL 28/1(1) 24.9 ± 0.52
skn-l(zu135);Ex(ges-1p::skn-1c::GFP) DR 29/0(1) 25.4 ± 0.81 P = 0.5829
skn-1(zu135);gelsl0[ges-lp::skn-1c::GFP] AL 44/1(1) 27.6 ± 0.61
skn-1(zu135);geIslO[ges-1p::skn-lc::GFP] DR 51/0(1) 27.8 ± 0.60 P = 0.7373
skn-1(zu135);Ex(gpa-4p::skn-1c::GFP) AL' 41/2(1) 22.7 ± 0.47
skn-1(zul35);Ex(gpa-4p::skn-1c::GFP) DR" 90/1(2) 22.3 ± 0.64 P = 0.9584
kylsl28 mock AL 96/1(2) 21.1 ± 0.37
kylsl28 mock DR 99/2(2) 26.2 ± 0.50 P < 0.0001
kylsl28 ASI-ablated AL 54/0(2) 23.4 ± 0.73
kylsl28 ASI-ablated DR 56/1(2) 24.4 ± 0.65 P = 0.3485
daf-16('mg50);kylsl28 mock AL 50/0(1) 18.0 ± 0.52
daf-16(mg50);kyls128 mock DR 53/0(1) 23.6 ± 0.51 P < 0.0001
daf-16(mg50);kylsl28 AS]-ablated AL 32/0(1) 18.9 ± 0.60
daf-16('mg50);kylsl28 ASI-ablated DR 33/0(1) 19.6 ± 0.74 P = 0.4342
N2 + DMSO AL 156/7(3) 26.6 ± 0.35
N2 + DMSO DR 143/19(3) 32.2 ± 0.43 P < 0.0001
N2 + DMSO/30 tM myxothiazol AL 41/0(1) 26.6 ± 0.57
N2 + DMSO/30 gIM myxothiazol DR 44/2(1) 28.6 ± 0.40 P = 0.0063
N2 + DMSO/60 gM myxothiazol AL 44/2(1) 26.2 ± 0.58
N2 + DMSO/60 jtM myxothiazol DR 51/0(1) 25.7 ± 0.60 P= 0.6307
N2 + EtOH AL 101/5(2) 25.6 ± 0.37
N2 + EtOH DR 63/27(2) 32.1 ± 0.66 P < 0.0001
N2 + EtOH/1 gM antimycin AL 98/5(2) 25.1 ± 0.35
N2 + EtOH/1 jiM antimycin DR 101/2(2) 23.1 ± 0.52 P= 0.0499
N2 plate + EtOH 44/3(1) 24.0 ± 0.49
N2 plate + EtOH/1 IpM antimycin 42/6(1) 25.6 ± 0.59 P = 0.0177b
daf-2(el370) plate + EtOH 48/2(1) 42.7 ± 0.87
daf-2(e1370) plate + EtOH/1 giM antimycin 48/2(1) 42.8 ± 0.92 P = 0.8973b
che-3(e1124) AL 57/48(2) 31.6 ± 0.71
che-3(e1124) DR 48/4(1) 38.5 ± 0.74 P < 0.0001
osm-5(p813) AL 68/38(2) 34.3 ± 0.81
osm-5(p813) DR 47/6(1) 41.1 ± 0.98 P< 0.0001
Is007 AL' 47/0(1) 25.5 ± 0.72
Is007 DR" 54/5(1) 32.8 ± 0.37 P < 0.0001
Shaded bars indicate the conditions used for all subsequent ad lib and calorie-restricted lifespans.
"Lifespan curve is not shown in figures.
"This P-value is vs. the non-antimycin control that immediately precedes it.
Supplementary Table S2. Lifespan data for supplementary figures.
Strain and condition # deaths/# censored(# trials) mean ± s.e.m p-value vs. AL control
N2 AL 832/50(17) 25.7 ± 0.14
N2 DR 792/60(16) 32.8 ± 0.18 P < 0.0001
skn-1(zu67) AL 92/11(2) 22.0 ± 0.38
skn-l(zu67) DR 102/0(2) 24.1 ± 0.53 P= 0.0005
skn-1(zul29) AL 51/1(1) 22.2 ± 0.43
skn-l(zu129) DR 38/14(1) 23.1 ± 0.74 P = 0.0243
N2" 46/4(1) 22.5 ± 0.65
skn-1(zu135)" 45/5(1) 21.8 ± 0.76
daf-2(e1370)" 48/2(1) 39.8 ± 1.33
skn-1(zul35);daf-2(e13 70)" 45/2(1) 45.2 ± 1.17
kyls128 unmounted AL 51/2(1) 21.6 ± 0.50
kylsl28 unmounted DR 53/0(1) 26.7 ± 0.63 P < 0.0001
kylsl28 mounted AL 96/1(2) 21.1 ± 0.37
kyls128 mounted DR 99/2(2) 26.2 ± 0.50 P < 0.0001
"This lifespan was performed on standard NGM + OP50 plates containing FuDR.

Figure 1. Lifespan extension by DR.
Lifespan curves represent combined data from independent experiments as indicated in
Supplementary Table Si. Complete lifespan data are presented in Supplementary Table
S1.
(a) Survival curves of wild-type N2 animals fed various concentrations of bacteria in
liquid medium, or on agar plates of otherwise identical composition seeded with a
bacterial lawn.
(b) Local maximum in N2 mean lifespan at optimal level of bacteria dilution. In contrast,
the lifespan of skn-1(zul35) is not altered by food level.
(c) The DR protocol extends lifespan of the insulin pathway mutants daf-16(mgDf50) and
daf-2(e1370). AL bacterial concentration = 2.5 x 108 cfu/ml; DR = 2.5 x 107 cfu/ml.
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Figure 2. skn-1 functions in the ASI neurons to mediate DR longevity.
(a) The skn-i gene encodes three protein isoforms, with different N-termini but a
common C-terminus. Predicted transcripts (Wormbase) and their genomic organization
are depicted, with exons shown in blue and UTRs in gray. Striped boxes indicate an
operonic transcript including the upstream gene, the beclin-1 homolog bec-1, and
downstream skn-la. The extent of the Is007[skn-i::gfp] integrated transgene 0o and the
insertion site of GFP in the transgene are also indicated. The purple and red dotted lines
indicate the DNA segments used in the skn-i(RNAi) and skn-lb(RNAi) constructs,
respectively (see text); the skn-ic(RNAi) construct was made using a fusion of the exons
indicated by the green dotted line. The sites of the zul69 and zu135 nonsense mutations
are shown. DBD = DNA binding domain. See Supplementary Fig. S2a for more detail.
(b) Two strains carrying skn-i mutations, zu135 and zu169, have normal basal lifespans,
but fail to respond to DR.
(c) Both skn-i mutants are rescued by the integrated transgene Is007, which drives skn-
i::gfp from its native promoter and expresses skn-l::gfp in the ASI neurons and the gut.
(d-f) The skn-lb isoform is expressed primarily in the ASI neuron, and skn-lc is
expressed primarily in the intestine. RNAi constructs specific to the unique 5' end of
either skn-lb or skn-ic (see panel a) were used to examine skn-i isoform expression.
Note that the skn-ic RNAi construct will also knock down endogenous skn-la due to
sequence identity in this region. The skn-i(RNAi) clone targets the 3' region common to
all skn-i isoforms (see panel a).
(d) Is007 expresses SKN-1B::GFP, but not SKN-1C::GFP, in the ASI. The indicated
RNAi constructs were fed to lin-35(n745);Is007[skn-1::gfp] animals. skn-lb(RNAi), but
not skn-lc(RNAi), reduced GFP expression in the ASI. Data shown is from two
independent experiments; errors are s.e.m. Total n of animals observed in trial 1, trial 2:
vector: 24, 29; skn-J(RNAi): 20, 24; GFP(RNAi): 22, 26; skn-1b(RNAi): 36, 24; skn-
Ic(RNAi): 23,20.
(e) Is007 expresses SKN-1C::GFP, but not SKN-1B::GFP, in the intestine. Following
RNAi exposure, Is007 worms were heat-shocked to induce nuclear accumulation of
SKN-1::GFP in the intestine. skn-lc(RNAi) reduced SKN-1::GFP, while skn-lb(RNAi)
had no effect. Data shown is from two independent experiments; errors are s.e.m. Total n
of animals examined in trial 1, trial 2: vector: 24, 25; skn-J(RNAi): 25, 23; skn-lb(RNAi):
28, 24; skn-lc(RNAi): 28, 21.
(f) skn-la and/or skn-lc account for the majority of basal skn-1 transcriptional activity in
the intestine. The gene dod-24 has several skn-1 consensus binding sites in its promoter
region and is expressed in a skn-l-dependent manner (data not shown). An integrated
dod-24p::gfp transgenic strain (a gift of D. Kim and F. Ausubel) was therefore used as a
reporter for intestinal skn-1 activity. skn-lc(RNAi) reduced reporter expression, while
skn-lb(RNAi) did not. Scale bars, 100 pRm.
(g) An extrachromosomal array that drives skn-1b::gfp expression from the gpa-4
promoter exclusively in the ASI neurons of adult animals rescues the skn-1(zul35) DR
longevity defect. Two independently transformed lines, labeled "#1" and "#2", are
shown. (h) An extrachromosomal array driving skn-1c::gfp expression from the ges-1
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promoter exclusively in the gut does not rescue skn-1(zul35) DR longevity. gelsl0, an
integrated version of the same array, also fails to rescue.
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Figure 3. The ASI neurons are necessary for DR longevity.
ASIs were laser-ablated in strains carrying the integrated array kyls128, which expresses
GFP from the ASI-specific str-3 promoter26. "Mock" strains represent non-operated
controls (see Methods).
(a) Animals with killed ASIs do not respond to DR. These animals have a longer basal
lifespan, as previously reported 17 (for kyls128 ASI- AL vs. kyls128 mock AL, Mantel-
Cox logrank P < 0.0001).
(b) daf-16 mutation suppresses the longer basal lifespan caused by ASI ablation (for daf-
16(mgDf50);kyls128 ASI AL vs. daf-16(mgDf50);kylsl28 mock AL, P = 0.3902), but
ASI-ablated animals remain refractory to DR.
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Figure 4. DR activates skn-1 in the ASI neurons and increases whole-body
respiration.
(a) 5 days of DR increases skn-1::gfp expression in the ASI neurons of s007. Left,
bright field and fluorescence Nomarski images. Scale bars, 10 p~m. Right, quantification
of fluorescence in Is007 and in gels8, a specificity control strain that drives skn-1::gfp
expression from the ASI-specific gpa-4 promoter. Each value represents pooled data
from two independent trials; errors are s.e.m. n for trial 1, trial 2: Is007 AL: n = 42, 42.
Is007 DR: n = 58, 21 (unpaired two-tailed t-test P < 0.0001). gels8 AL: n = 19, 31;
gels8 DR: n = 19, 39 (P < 0.0001).
(b) Respiration rate is increased in N2 animals assayed on day 3 of DR. The skn-
1(zu135) mutation prevents the respiration increase on DR. Integrated transgenes
driving skn-l::gfp expression, either from the native promoter (Is007), or from the ASI-
specific gpa-4 promoter (gels9), rescue the DR respiration defect of skn-1(zu135),
elevating respiration rates above the wildtype level. The integrated transgene gelsl0,
which drives skn-1::gfp expression in the gut using the ges-1 promoter, fails to rescue
the respiration defect of skn-1(zul35) on DR. Unpaired two tailed t-test p-values, AL vs.
DR for each strain: N2: P = 0.0221; skn-1(zu135);Is007: P = 0.0011; skn-
1(zu135);gels9: P = 0.0005. No other values differ significantly from N2 AL. N2 data
represents pooled triplicate measurements from each of four independent experiments.
Other strains were measured in triplicate in two experiments each; errors are s.e.m.
(c - d) Electron transport chain inhibiting drugs prevent the DR longevity response
without shortening AL lifespan. The ETC complex III inhibitor myxothiazol partially
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blocks DR longevity at 30 [IM, and completely blocks DR longevity at 60 [tM (c).
Another complex III inhibitor, antimycin, also blocks DR longevity (d).
(e) Antimycin does not affect the longevity induced by daf-2(e1370) mutation. This
assay was performed on agar plates with otherwise identical composition to the liquid
medium used for DR experiments.
(f) The DR longevity response does not require environmental chemosensation. che-
3(e1124) and osm-5(p813) mutants lack functional sensory neuron cilia and are long-
lived under AL conditions30 , but DR still increases lifespan in these mutants by a similar
percentage as it does in N2.
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Supplementary Figure SI. Fat storage and progeny production are reduced in DR
animals.
(a) Representative day 3 adult animals cultured on plates, in AL liquid medium, or DR
liquid medium, with fat stained by Sudan Black 31. Staining is observed in the anterior and
posterior gut of plate-cultured and AL-cultured animals (black arrows), but is reduced or
invisible in DR animals (white arrowheads). Staining is also visible in intrauterine eggs in
all conditions. Also note the small size of the DR animals. Scale bars, 100 [m.
(b) Quantification of individuals with any visible intestinal fat staining on day 3 of plate
feeding, AL feeding, or DR feeding. Fat staining is significantly reduced in DR vs. AL
animals (unpaired two-tailed t-test, p < 0.0001). Similar results were obtained at later
timepoints (data not shown). Each value on the graph represents two independent
experiments; errors are s.e.m. Total n of animals examined in trial 1, trial 2: N2 plate: n =
24, 35; N2 AL: n = 23, 31; N2 DR: n = 27, 32.
(c) Progeny production is optimal in AL animals, while DR animals have reduced overall
progeny production and extended reproductive period. Errors on graph are s.e.m. Total
progeny + SI), total n animals examined: AL: 308 ± 26, 21; DR: 152 ± 34, 20.
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Supplementary Figure S2. 5' RACE indicates that the skn-lb mRNA is derived from
a different promoter than those of skn-la and skn-lc.
(a) The skn-1 genomic locus encodes three protein isoforms, SKN-1A, SKN-1B, and
SKN-1C, which have different N-termini but identical C-termini. Predicted transcripts
(Wormbase) are depicted, with exons shown in blue and UTRs in gray. (Pink exons
indicate predicted gene T 19E7.1, which is transcribed from the opposite strand.) Striped
boxes indicate an operonic transcript including the upstream gene, the beclin-1 homolog
bec-i, and downstream skn-la. The identities of the mutants described in this report are
indicated; amino acid positions are relative to the first amino acid in SKN-1C. The extent
of the Is007 transgene and the insertion site of GFP in the transgene are also indicated.
DBD = DNA binding domain. P1 - P4 indicate the positions of primers used for 5'
RACE and RT-PCR (see panels b - c). C. elegans mRNAs are often trans-spliced at their
5' ends to short RNA leaders encoded elsewhere in the genome, termed SL1 and SL232
PSL 1 and PSL2 are primers identical to the SL 1 and SL2 leader sequences, which will
anneal to the 5' ends of SL 1 and SL2 trans-spliced cDNAs. PSL 1 and PSL2 are
positioned on the diagram at the sites of predicted SL1 and SL2 trans-splice acceptor
sequences in the skn-la and skn-lc transcripts (Wormbase).
(b - c) RT-PCR confirms that skn-la and skn-Ic mRNAs are trans-spliced, but provides
no evidence that skn-lb mRNA is trans-spliced. This difference in the 5' ends of the three
skn-1 isoforms' transcripts suggests that the skn-lb transcript is derived from a separate
promoter than those of skn-la and skn-1c, rather than resulting from alternative splicing
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of skn-la and/or skn-lc transcripts. Ladder sizes in bp are indicated to the left of each gel.
Low molecular weight smears in each lane are unincorporated nucleotides.
(b) RT-PCR confirms predicted SL1 and SL2 trans-splicing in skn-la and skn-lc mRNA.
Primer PSL1, which anneals to the trans-spliced skn-la and skn-lc cDNAs, and primer
P2, which spans the skn-lc exon 3-exon 4 junction, produce two products of the expected
0.6 kb and 0.9 kb sizes. Primer PSL2, which anneals to the trans-spliced skn-la cDNA,
and primer P2 produce a product of the expected 0.9 kb size. A positive control
amplification with primer P1, which is at the 5' end of skn-lc exon 1, and primer P2
produces a band of the expected 0.3 kb size, confirming that skn-lc and/or skn-la cDNA
was present in the template.
(c) RT-PCR does not indicate any trans-splicing of the skn-lb transcript. Primer PSL1,
which is not predicted to anneal to skn-lb cDNA since skn-lb cDNA is not predicted to
be trans-spliced, and primer P4, which spans the skn-lb exon 1-exon 2 junction, produce
no product. Primer PSL2, which is not predicted to anneal to skn-lb cDNA, and primer
P4 produce no product. A positive control amplification with primer P3, which is at the
5' end of skn-lb exon 1, and primer P4 produces a band of the expected 0.2 kb size,
confirming that skn-lb cDNA was present in the template.
(d) 5' RACE using a primer specific for skn-lb also indicates no trans-splicing. The 5'
cDNA ends cloned in the RACE reaction are listed, with the translational start codon in
capital letters. Each clone carried between 1 and 31 bp of genomic sequence immediately
upstream of the translational start. Heterogeneous transcriptional initiation within a 30 -
50 bp range is typically observed in C. elegans genes (cf. ref 33), suggesting that some or
all of these products represent bona fide full-length transcripts. The results of the 5'
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RACE suggest that skn-lb is transcribed from a promoter that lies almost immediately
upstream of the translational start site, rather than being derived from one of the other
skn-1 transcripts by alternate splicing.
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Supplementary Figure S3. Two additional alleles of skn-1 impair the DR longevity
response.
N2 mean lifespan is extended by 27.6%, while skn-l(zu67) and skn-1(zul29) are
extended only 9.5% and 4.1%, respectively. Complete lifespan data are presented in
Supplementary Table S2.
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Supplementary Figure S4. skn-1(zul35) does not suppress the long lifespan of daf-
2(e1370).
This assay was performed on standard NGM + OP50 plates containing FuDR. Complete
lifespan data are presented in Supplementary Table S2.
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Supplementary Figure S5. The gross morphology and cell fate of the ASI neurons
are not disrupted by skn-1(zu135).
(a) Gross morphology of the ASI neurons is normal in skn-1(zul35) mutants. Nomarski
bright field (top) and fluorescence images; the ASI is highlighted by expression of an
integrated srd-1p::gfp transgene. Axon (black arrowheads), cell body, and dendrite all
appear normal. Scale bars, 10 Jim.
(b) ASI cell fate is not altered by skn-1(zul35). Expression of integrated GFP reporter
constructs that serve as markers of ASI cell fate was examined in AL and DR conditions.
Four of the five reporters were expressed normally in a skn-1(zu135) background,
indicating that ASI cell identity is broadly preserved. The expression level of these four
reporters was not altered by DR (data not shown). One ASI reporter construct, sra-
6p::gfp, was dependent on skn-1 for expression, and showed a modest increase in
expression level on DR (N.B. and L.G., unpublished results). Ex(gcs-1::gfp) has
previously been reported to be dependent on skn-1 for expression in the ASI neurons 1 .
We confirmed that skn-1(zul35);Ex(gcs-I::gfp) does not express GFP in the ASI neurons
under AL conditions, but we did observe skn-l-independent expression under DR
conditions. The expression level ofEx(gcs-l::gfp) was not significantly altered by DR
(data not shown).
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a Ex(gcs-1.:gfp) was not expressed in the ASI of skn-1 animals under ad lib conditions, but was
expressed independently of skn-1 during DR.
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Supplementary Figure S6. Arsenate resistance is mediated by intestinal activity of
skn-1.
Adult animals were placed on 5 mM sodium arsenate NGM plates seeded with OP50, and
survival was assayed after 48 hr. skn-1(zul35) exhibited marked arsenate sensitivity that
could be rescued by Is007[skn-1::gfp], consistently with a previous report 34. The
intestine-specific Ex(ges-lp::skn-1c::gfp) transgene efficiently rescues arsenate
sensitivity, as does gelslO, an integration of the same transgene. In contrast, a transgene
expressing primarily in the ASI neuron, gels9[gpa-4p::skn-1b::gfp], does not rescue
arsenate sensitivity. Each value represents pooled data from multiple independent
experiments; errors are s.e.m. Number of trials, n for each experiment: N2: 3 trials, n =
18, 24, 22; skn-1(zu135): 4 trials, n = 25, 22, 19, 16; skn-1(zu135);Is007: 3 trials, n = 23,
35, 27; skn-1(zul35);Ex(ges-lp::skn-1c::gfp): 2 trials, n = 15, 34; skn-1(zu135);geIslO: 2
trials, n = 16, 20. skn-1(zu135);gels9: 2 trials, n = 20, 23.
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Supplementary Figure S7. The short lifespan of kylsl28[str-3p::gfp] is intrinsic to
the strain, and not due to the laser-ablation mounting procedure.
"Mock" worms were mounted in sodium azide; other strains were not. Even without
mounting, the kyls]28 strain lives shorter than N2. Mounting had no effect on the
lifespan. Complete lifespan data are presented in Supplementary Table S2.
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CHAPTER 3
A Conserved MAPK Pathway Mediates Dietary Restriction-Induced
Longevity in C. elegans
This chapter will be submitted for publication. The authors will be Nicholas A. Bishop
and Leonard Guarente.
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Summary Paragraph
Dietary restriction (DR) extends the lifespan of many organisms and reduces
incidence and progression of age-related disease in mammals'. Until recently, almost
nothing was known of the genetic pathways underlying DR-induced longevity in
metazoans. We previously reported that the transcription factor skn-1 acts specifically in
two C. elegans head neurons, called the ASIs, to mediate DR-induced longevity by
signaling to peripheral body tissues (Chapter 2). Here, we identify sek-1, a conserved
stress-responsive MAPKK homologous to mammalian MEK3/6 2-8, as essential for DR-
induced longevity and several other physiological responses to DR. We show that sek-1
acts in the ASI neurons to maintain skn-1 expression and mediate the DR longevity
response. During DR, sek-1 functions downstream of the MAPKKK nsy-1, a homolog of
the mammalian MAPKKK ASK1 9,10. Thus, we have established a three-member genetic
pathway that mediates DR longevity by acting in the ASI neurons. These results provide
new genetic insight into the DR response in metazoans, and suggest that activation of a
stress-sensitive MAPK pathway in the brain is a crucial initial event in DR-induced
longevity.
Results
We developed a method of imposing DR in C. elegans in which worms are
cultured in a small volume of liquid medium with controlled bacterial density (see
Methods). In wild-type worms, lifespan increases as bacterial concentration is reduced
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until a maximum is reached at an optimal food level, but further food reduction causes
reduced longevity due to starvation (Figure lA, Table Si). The genetic mechanisms
underlying the DR-induced increase in lifespan are poorly understood.
DR Increases Lifespan by a Different Mechanism Than Known Longevity Mutants
Many mutations have been identified in C. elegans that alter longevity by
modulating several parallel genetic pathways"1 , but very little is known about the genetic
mechanism by which DR increases lifespan. We therefore tested a panel of mutants
affecting known lifespan control pathways for a role in DR longevity by exposing each
mutant to the optimal level of DR and evaluating epistasis (Table 1; also see reference
12). As we previously reported (Chapter 2), DR extends the lifespan of mutations
affecting the insulin signaling pathway"I or sensory perception 13 at least as effectively as
the wild type. Sterile mes-l(bn7) animals, which are long-lived due to absence of the
germline4, 15, showed a lifespan increase under DR, as did two mutants that disrupt the
germlineless longevity pathway, daf-9(rh5O) and daf-12(m20) 15,16. Importantly,
observation of DR-induced longevity in animals lacking the germline argues that the
longevity effect of DR is separable from the concomitant reduction in fecundity observed
in any species undergoing DR 7. Sir2 regulates lifespan in several species and is required
for dietary restriction to increase longevity in yeast and flies ,' 19. A deletion mutant, sir-
2.1 (ok434) 20, did not prevent a normal DR-induced lifespan extension. In summary, all
the longevity mutants tested, including representatives of the insulin signaling, sensory
perception, germline, and sirtuin longevity pathways, responded robustly to DR,
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suggesting that DR increases lifespan by a genetic pathway largely distinct from these. A
caveat of this; conclusion is that the daf-2, daf-9, and daf-12 alleles tested were partial
loss of function mutations, rather than null alleles, so it remains formally possible that
any of these could play some role in DR longevity.
Mutants Disrupting the sek-1 MAPKK Pathway Cause Defects in Multiple Physiological
Responses to DR
We previously reported that, in contrast to the wild type, the lifespan of worms
carrying mutations in the transcription factor skn-1 was not altered by food concentration,
indicating that skn-1 is required for the DR longevity response (Chapter 2). Because the
MAPKK sek-1 has been shown to regulate skn-1, at least in the intestine , we tested
whether sek-1 might also function in DR longevity. The lifespan of sek-1(km4) animals
was not altered by diet (Figure lA, Table S ), consistent with a requirement for sek-1 in
the DR longevity response. An additional allele, sek-l(agl), also exhibited a dramatic
reduction in lifespan increase under DR (Figure 1B, Table Si). sek-l(km4) is a large
deletion and a presumed null allele, while sek-1(agl) is a missense mutation in a single
amino acid (Figure 2A), likely accounting for the more modest mutant phenotype of sek-
1(agl). Although worms carrying either allele of sek-1 exhibited a slightly shorter basal
lifespan than the wild type at the AL food level (Figure 1B), this defect of sek-1 mutants
is separable from the failure to increase lifespan on DR (see below). Because sek-l(km4)
is a probable null allele and has the stronger effect on DR, we focused our subsequent
analyses on this allele. The possibility that sek-1 mutation might simply impose an
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absolute limit on lifespan was ruled out by the observation that the daf-2(e1370) mutation
could extend the lifespan of a sek-1 mutant (Figure Si), consistent with a previous
report21. The longevity defects of sek-1 animals, in both response to DR and basal
lifespan, were rescued by an extrachromosomal array carrying a 10 kb genomic fragment
including the wild-type sek-1 gene (Figures IC and 2A, Table Si), confirming that the
mutation in sek-1 was responsible for the observed phenotype.
The MAPKKK NSY-1 phosphorylates SEK-1 as part of a signaling module, and
nsy-1 mutants phenocopy sek-1 mutants in most respects3' 5. We therefore tested the
longevity of nsy-1(ky397) mutants under DR, and found that, like sek-1 mutants, nsy-1
animals failed to increase lifespan in response to DR and had a slightly short basal
lifespan (Figure ID, Table S1), suggesting that nsy-1 acts upstream ofsek-1 in the DR
response. The CamKII unc-43 acts immediately upstream of nsy-1 during the
development of the AWC neuronso0 , but the unc-43(n1186) mutant exhibited a normal
lifespan increase during DR (Table Si), so the genes acting upstream of nsy-1 during DR
remain to be identified.
We next tested whether other physiological responses to DR, in addition to
lifespan modulation, were affected by sek-1 mutation. Multiple organisms, including
yeast, worms, and mammals, increase respiratory rate during DR 22-25, and there is
evidence that this respiration increase is necessary for DR to increase longevity in yeast 22
and worms (Chapter 2). Wild-type worms increased respiration during DR, but sek-1
mutants, in contrast, had decreased respiratory rate under AL conditions that was not
increased by DR (Figure IE). Both the low basal respiration and the defect in DR-
induced respiration were rescued by the extrachromosomal wild-type sek-1 transgene,
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confirming that the mutation in sek-1 was responsible for the observed respiratory defects
(Figure lE).
DR leads to reduced body fat26. In C. elegans, the intestine serves as the primary
fat storage organ. We measured steady-state intestinal fat levels in AL and DR worms
using the triglyceride stain Sudan Black, and found that wild-type worms exhibited fat
levels during DR that were reduced by about half relative to AL worms (Figure IF and
S2). Interestingly, sek-1 mutant worms had a fat level comparable to that observed in DR
wild-type animals regardless of food concentration (Figure 1F and S2), indicating that
sek-1 is necessary for appropriate coupling of fat storage to diet.
Taken together, these findings show that mutants that disrupt sek-1 activity cause
defects in the translation of food availability into appropriate modulation of multiple
physiological responses.
sek- 1 Regulates skn- 1 Expression in the ASI Neurons
To gain further insight into how sek-1 acts to mediate DR longevity, we
characterized the expression pattern of gels7, an integrated translational sek-l::gfp
reporter (Figure 2A). The reporter expressed strongly in many, though not all, neurons,
including a number of head and tail neurons and the dorsal and ventral nerve cords
(Figure 2B). The reporter also expressed in the intestine, spermathecae, and distal tip
cells. Importantly, sek-1::gfp expression was observed in the two ASI neurons in the head
(Figure 2C), which play a crucial role in DR longevity (Chapter 2).
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skn-1 acts specifically in the ASI neurons to mediate DR-induced lifespan
extension. Given the known regulation of skn-1 by sek-1 in the intestine6, we investigated
whether skn-1 is also regulated by sek-1 in the ASI neurons. Using Is007, an integrated
skn-l::gfp reporter27 , we found that sek-1 is required for maintenance of skn-1 expression
in the ASI neurons of adult animals. By the fifth day of adulthood, ASI neuronal SKN-
1::GFP expression is maintained in the wild-type but almost completely lost in the sek-1
background (Figure 2D). We confirmed that sek-1 acts cell-autonomously to maintain
SKN-1 expression in the ASI neurons by rescuing the SKN-1::GFP expression defect of
sek-1(km4);Is007 worms with an extrachromosomal transgene that drives a sek-
1::mStrawberry red-fluorescent fusion28 from the ASI-specific gpa-4 promoter29 (Figure
2D and S3).
Regulation of skn-1 by sek-1 in the ASIs was dependent on the native skn-1
promoter, because gels8, an integrated transgene driving skn-l::gfp expression from the
gpa-4 promoter (Chapter 2), was not affected by sek-1 mutation (Figure 2E). This
observation suggests that sek-1 regulates skn-1 at the transcriptional level. Transcriptional
regulation of skn-1 by sek-1 in the ASI neurons differs from the situation in the intestine.
In the intestine, SEK-1 activates SKN-1 by first phosphorylating the p38 MAPK
homologue PMK-1, which then phosphorylates cytoplasmic SKN-1 protein, driving
relocalization of SKN-1 to the nucleus6. The dominant SKN-1 protein isoform expressed
in the ASI neurons, by contrast, is constitutively nuclear and lacks one of the two p38
phosphorylation sites present in the dominant intestinal SKN-1 isoform6 . This suggests
that the genes connecting sek-1 to skn-1 in the ASIs are likely to differ from those
connecting the two in the intestine. In confirmation of this prediction, pmk-1 was not
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required for normal SKN-1::GFP expression in the ASI neurons or for normal lifespan
increase in response to DR (Figure 2D, Table Si). There are two other p38 MAPK
homologues in C. elegans, pmk-2 and pmk-3, which could act downstream of sek-1 in the
ASI 30. However, the deletion pmk-3(okl69) responded normally to DR (Table Si), and a
strain carrying the pmk-2(gk21) deletion exhibited completely penetrant larval arrest, so
its lifespan could not be tested. Therefore, the genes acting downstream of sek-1 to
regulate skn-1 in the ASI remain to be identified.
sek- 1 Acts Separately in the ASI Neurons and the Intestine to Influence Lifespan by Two
Different Mechanisms
DR induces an increase in SKN-1::GFP expression in the ASI neurons of Is007
worms (Chapter 2). The very low expression level of SKN-I::GFP in sek-1;Is007
animals was not increased by DR (Figure 2F), indicating that sek-1 acts downstream of or
in parallel to DR to regulate skn-1. Given the known requirement of skn-1 in the ASI
neurons for DR-induced longevity, this result suggested that sek-1 mutant worms might
fail to respond to DR due to lack of sek-1 activity specifically in the ASI neurons. We
tested this hypothesis by introducing an ASI-specific gpa-4p::sek-l::gfp transgene into
sek-l(km4) animals and assessing rescue of DR longevity defects. In each of two
independent transgenic lines, we observed full rescue of the DR longevity response
(Figure 3A). Interestingly, the short basal lifespan was not substantially rescued by this
transgene. This result indicates that sek-1 is required specifically in the ASI neurons to
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mediate the DR longevity response, but also has a separate function in another tissue(s) to
assure normal basal lifespan.
sek-1 has known stress-resistance functions in the intestine6 , so we examined
whether sek-1 activity is needed in the intestine to promote normal basal longevity. Two
transgenic lines in which the intestine-specific ges-1 promoter"3 drove sek-l::gfp
expression revealed that intestinal sek-1::gfp expression is sufficient to rescue the short
basal lifespan of the sek-l(km4) mutant (Figure 3B). Unlike the ASI-specific sek-l::gfp
transgene, this intestinal transgene did not appreciably rescue the DR-induced longevity
defect, confirming that sek-1 influences two separate lifespan control pathways in the two
tissues.
Discussion
Taken together, these results suggest a model in which sek-1 and nsy-1 act in two
separate tissues to affect lifespan in two different ways (Figure 4). First, sek-1 and nsy-1
act in the intestine to assure a normal basal lifespan under all dietary conditions. Because
pmk-i is known to mediate most effects of sek-1 in the intestine21, and pmk- (km25) itself
has a short basal lifespan (Table S ), pmk-i is likely also to act in this intestinal basal
lifespan pathway. Second, sek-1 and nsy-1 act in the ASI neurons to maintain skn-i
expression and to mediate the DR-induced increase in lifespan in a pmk-l-independent
manner.
sek-i is known to be critical in resistance to multiple environmental stressors,
such as heavy metals, oxidative damage, and pathogen infection, predominantly through
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its action in the intestine4-6 . The attenuation of cell-autonomous intestinal stress responses
in sek-1 animals likely accounts for their short basal lifespan. It is intriguing that, in
contrast, the ]DR longevity response requires activity of the sek-1 pathway primarily in
two cells, promoting a cell-nonautonomous signal that extends lifespan.
We do not know the precise nature of the stimulus that activates nsy-1 in the ASI
neurons during DR. The mammalian homolog of nsy-1, ASK1, is primarily activated by
cellular stress, mainly in the form of reactive oxygen species (ROS) and/or ER stress9
This suggests that DR may initially produce an increase in ROS, a more oxidizing
cytoplasmic environment, and/or ER stress in the ASI neurons to promote longevity by
initiating cell-nonautonomous signals via skn-1. Consistent with this idea, genomic
transcriptional profiling of murine hypothalamic gene expression following fasting
revealed that one of the ten most significantly induced transcripts encoded thioredoxin-
interacting protein 32, which activates ASK1 in mammalian cells by competitively binding
the ASKI-inhibitory protein, thioredoxin9 33. Interestingly, neuronal expression of the
worm thioredoxin homologue, trx-1, is limited to the ASI and ASJ neuronal pairs34
The ýMAPK that acts downstream of sek-1 to regulate skn-1 in the ASI neurons
remains elusive. However, the closest mammalian homologues of sek-1, MEK3 and
MEK6, exclusively activate the p38 MAPKs2, and sek-1 is, similarly, an essential
upstream activator of the p38 MAPK homologue pmk-1 4. It is therefore reasonable to
assume that sek-1 acts on a p38 MAPK(s) to mediate DR longevity. The worm genome
contains three p38 MAPK homologues, pmk-1,-2, and -3 30, though since neither deletion
of pmk-1 nor pmk-3 can suppress DR longevity, the most likely candidate is pmk-2.
Alternately, two or more MAPKs may mediate signaling from sek-1 redundantly. The
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ASI neurons likely respond to DR-induced cellular stress by releasing hormonal cues that
adapt the worm's metabolism to the restricted diet. By analogy, mammalian p38 MAPKs
are activated in the hypothalamus by fasting and deactivated by re-feeding 35' 36, and can
regulate secretion of certain pituitary hormones3 7, 38
The notion that stress-responsive pathways might mediate DR longevity has been
suggested before, as part of the "Hormesis Hypothesis" of DR longevity3 9. Proponents of
this hypothesis suggest that DR extends lifespan by inducing cell-autonomous general
stress-response pathways throughout the body. The present results confirm the predicted
importance of a stress resistance pathway in mediating DR longevity, but surprisingly,
this pathway need function in only two cells, the ASI neurons, to promote longevity of
the whole animal.
We have identified a genetic pathway, homologous to a stress-responsive MAPK
pathway in humans, that mediates DR longevity by acting in two neurons of C. elegans.
There is ample evidence that cellular stress-responsive genes and pathways are activated
in many tissues during DR in mammals39. An interesting theme that is beginning to
emerge from the identification of genes mediating DR longevity in C. elegans is that
genes known to be important for cell-autonomous stress resistance in peripheral tissues
are proving also to be important in DR longevity, but their critical actions lie in just a few
brain neurons. In specialized neurons that control organismal metabolism, such as the
ASIs and hypothalamic neurons, stress response pathways that generally induce
cytoprotective functions may instead be coupled to hormonal signaling. Further work
will be needed to confirm this hypothesis. Given the wealth of pharmacologic modifiers
of MAPK pathways already available, however, MAPK pathways in hypothalamic
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neurons represent an exciting possible target for future therapeutics to extend healthy
lifespan in humans.
Methods
Strains
We used the following strains: the wild-type N2, KU4 sek-1(km4), AU1 sek-
J(agl), LG320 sek-l(km4);Ex(sek-1) #1, LG311 nsy-1(ky397), CB1370 daf-2(e1370),
GR1307 daf-16(mgDf50), CB1124 che-3(el 1124), PR813 osm-5(p813), LG231 sir-
2.1(ok434), I)R20 daf-12(m20), AA111 daf-9(rh50), SS149 mes-l (bn7), LG330
gels7[sek-l::gfp], the Is007[skn-J::gfp] strain 27, LG318 sek-(km4);Is007, KU25 pmk-
1 (km25), LG3 16 pmk- 1(km25);Is007, LG344 gels8[gpa-4p::skn-lb::gfp], LG346 sek-
1(km4);gels8, LG351 sek-l(km4);Ex(gpa-4p::sek- ::rfp), LG353 sek-1(km4);Ex(ges-
lp::sek-1:::gp) #1, LG352 sek-1;Ex(ges-lp::sek-I::gfp) #2, LG374 sek-1;Ex(gpa-
4p::sek-l::g1p) #1, LG375 sek-1;Ex(gpa-4p::sek-1::gfp) #2, LG325 daf-2(e1370);sek-
1(km4), MT2605 unc-43(e1186), VC36 unc-5(gk29) pmk-2(gk21)/nTI and BS3383 pmk-
3(ok169).
Transgenic Strain Construction
Extrachromosomal array-carrying transgenic strains were generated using
standard microinjection methods. The 10 kb sek-1 rescue transgene was derived from a
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PCR product containing the sek-1 coding region, 5.6 kb of 5' promoter sequence, and 1.0
kb of 3' sequence, amplified from cosmid C38G3 using primers 5'-
GGCATATGGCTTTTCTAAGAAGTGAATGTGAAAGCA-3' and 5'-
CCGGTACCATCCCAATCAAGTCGTAGTGTG-3', and was injected at 5 ng/4L with
50 ng/p~L pRF4 as a co-injection marker.
To generate the integrated sek-l::gfp reporter strain gels7, plasmid pNB82 sek-
1::gfp::sek-1 3'UTR was constructed as follows. PCR fragment A, consisting of a portion
of the last intron of sek-1 and the last exon of sek-1 fused to GFP, was amplified from the
plasmid "pPD95.75-sek- pSEK-1+GFP fusion"3 primers 5'-
CTGAATTCATTCATTGCAGATTCTCG-ACACTGTTTGGCGACGATG-3' and 5'-
CCGATATCCTATTTGTATAGTTCAT-CCATGCCATGTGTAATCCCA-3'. Fragment
A was then digested with EcoRI and EcoRV. Fragment B was produced by first digesting
pNB65, an 8kb genomic subclone of the sek-1 locus containing the entire coding region
plus 3.6 kb of 5' sequence and 1.0 kb of 3' sequence, with EcoRV/EcoRI and gel
purifying the 2.2 kb fragment, then digesting this 2.2 kb fragment with MluI and gel
purifying the resultant 1.6 kb fragment. Finally, a separate sample of pNB65 was digested
with BsaBI and MluI, and the 9.1 kb vector fragment was gel purified to yield fragment
C. Fragments A, B, and C were trimolecularly ligated to yield plasmid pNB82. This
plasmid was injected at 50 ng/[pL to generate an extrachromosomal array-carrying line,
from which four independent integrants, gels4- 7, were isolated from a standard y-ray
integration screen, and were backcrossed three times to N2 prior to analysis. All four
integrants showed a similar expression pattern.
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To generate the sek-1;Ex(ges-lp::sek-1::gfp) strain, first a 1.3 kb fragment of the
ges-1 promoter was generated by amplifying N2 genomic DNA with primers 5'-
AATCTAGALATCTGAATTCAAAGATAAGATATGTAATAGATTTTTGAAG-3' and
5'-CTCATACATCATTGTCAAGTGACG-3', then digesting with HindIII/XbaI. This
ges-1 promoter fragment was inserted into HindIIl/XbaI-cut plasmid "sek-lp sek-
1KN+GFP fusion"3, which contains a kinase-dead point mutant sek-1 cDNA/GFP fusion,
to yield pNB73, a translational fusion of the ges-1 promoter to kinase-dead sek-l::gfp.
The kinase-dead mutation was restored to wild-type by the insertion of wild-type sek-1
cDNA sequence to yield pNB74 ges-1p::sek-l::gfp. This plasmid proved to drive only
very mosaic intestinal expression when injected into worms, however, so the ges-1
promoter was extended from 1.3 kb to 2.5 kb as follows. 2.5 kb of the ges-1 promoter
was amplified from cosmid C29B10 using primers 5'-
AAGCATGCGACCCAATGGAAACTGCAAAAATCT-3' and 5'-
AAGGTACCCTGAATTCAAAGATAAGATATGTAATAGATTTTTGAAGCC-3', and
the resultant product cut with SphI/KpnI and ligated into SphI/KpnI cut pPD95.75 to
yield pNB 123 ges-lp::gfp. pNB 123 was cut with XhoI/Bgl2 and inserted into XhoI/Bgl2-
cut pNB74 to yield pBR1 ges-lp::sek-l::gfp, the version of the construct used in this
report (this ligation performed by B. Redding, for which we are grateful). pBR1 was
injected at 50 ng/[tL along with 50 ng/gL pRF4, into sek-1(km4) animals to yield sek-
1(km4);Ex(ges-1p::sek-1::gfp), and the transformed worms exhibited robust intestinal
expression.
To generate the sek-1;Ex(gpa-4p::sek-l::rfp) strain, a cDNA clone of sek-1 was
amplified from pNB74 using primers 5'-
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AAGGATCCATGGAGCGAAAAGGACGTGA-3' and 5'-
CCTTTACTCATTTTTTCTACCGGTACCCT-3' and digested with BamHI/KpnI to
yield fragment A. A plasmid derivative of pPD95.70 (a gift of H. Schwartz) in which the
GFP cassette had been replaced by cDNA encoding the red-fluorescent mStrawberry18
was digested with KpnI/SpeI to excise the RFP region, fragment B. Fragments A and B
were trimolecularly ligated into BamHI/Spel cut pNB121 gpa-4p::skn-lb::gfr (see
Chapter 2) to yield pNB130 gpa-4p::sek-l::rfp. pNB130 was injected at 50 ng/RL, along
with 50 ng/[tL pRF4, into sek-l(km4) animals to yield sek-l(km4);Ex(gpa-4p::sek-
1 : rfp).
To generate the sek-1;Ex(gpa-4p::sek-l::gfp) strain, the gfp cassette from
pPD95.75 was swapped in for the rfp cassette in pNB130 by digestion with KpnI/SpeI to
generate pNB137 gpa-4p::sek-l::gfp. pNB137 was injected at 50 ng/LL, along with 50
ng/RL pRF4, into sek-1(km4) animals to yield sek-l(km4);Ex(gpa-4p::sek-J::gfp).
Dietary Restriction Protocol
Dietary restriction was performed as described in Chapter 2. Briefly, lifespan
assays were performed in the outer four wells of 6-well tissue culture plates, with each
well containing 2.5 ml DR Bottom Medium and 2.5 ml DR Top Medium. DR Bottom
Medium is composed of standard NGM medium 40, supplemented with 1 mg/ml
erythromycin to prevent bacterial division, 12.5 jtg/ml fluorodeoxyuridine to inhibit
progeny hatching, 50 Rg/ml ampicillin, and 1 mM IPTG; DR Top Medium is identical to
DR Bottom Medium, excluding the agar. Ampicillin-resistant bacteria were added from a
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concentrated stock to the desired concentration, and concentration was monitored
spectrophotometrically. Worms were grown to the L4/young adult stage on NGM plates
seeded with OP50 bacteria, then transferred individually into the wells and maintained at
20'C with gentle gyrotory shaking at 80 rpm.
Lifespan Assay
Lifespan assays were performed as described in Chapter 2.
Respiration Assay
Respiration assay was performed as described in Chapter 2. Briefly, mass plate
cultures of synchronized worms were grown on OP50 plates to the L4 stage, then
transferred to Erlenmeyer flasks containing AL or DR levels of bacteria. After three days
of culture, animals were collected by centrifugation and washed free of bacteria in S
buffer. Respiration rate was measured at 250 C using a Clark-type oxygen electrode
(Microelectrodes Inc.). Protein concentration in each sample was measured and oxygen
consumption rates were normalized to protein content.
Dil Staining
Young adult worms were incubated for 2 hours at room temperature in M9
buffer40 supplemented with 10 ýtg/mL Dil (Molecular Probes). Worms were transferred
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to NGM plates seeded with OP50 bacteria for 1 hour, and then visualized by Nomarski
microscopy with a FITC filter.
Fluorescence Intensity Quantification
Fluorescent images were collected at 1000x magnification (Zeiss) from worms
subjected to 5 days of AL or DR as described above. Fluorescence brightness in the ASI
was quantified using NIH ImageJ software.
Sudan Black Fat Staining
Day 3 adults cultured on plates, in AL conditions, and in DR conditions were
stained as described in Chapter 2.
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Table 1. Interaction of Known Lifespan Mutants with DR Longevity
Lifespan Pathway Strain and Condition # Deaths/# Censored Mean ± s.e.m. P-value vs.
Affected (# Trials) AL Control
Wild type
Insulin
Insulin
Sensory Neuron
Sensory Neuron
Germline
Germline
Germline
Sirtuin
N2 AL
N2 DR
daf-2(e1370) ALa
daf-2(e1370) DRa
daf-16(mgDf50) ALa
daf-16(mgDf50) DRa
che-3(e1124) ALa
che-3(e1124) DRa
osm-5(p813) ALa
osm-5(p813) DRa
mes-1(bn7) fertile AL
mes-1(bn7) fertile DR
mes-1(bn7) sterile AL
mes-l(bn7) sterile DR
daf-12(m20) AL
daf-12(m20) DR
daf-9(rh50) AL
daf-9(rh50) DR
sir-2.1(ok434) AL
sir-2.1(ok434) DR
All P-values are relative to AL control, unless otherwise noted.
aData from Bishop and Guarente, 2007.
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563/23(11)
513/15(10)
23/22(1)
32/21(1)
51/2(1)
53/1(1)
57/48(2)
48/4(1)
68/38(2)
47/6(1)
47/0(1)
49/3(1)
26/12(1)
42/6(1)
59/1(1)
52/2(1)
55/4(1)
47/1(1)
36/1(1)
52/2(1)
25.5 + 0.2
33.2 + 0.2
39.0 + 2.11
60.0 + 2.7
20.7 + 0.80
28.4 + 0.37
31.6 + 0.71
38.5 + 0.74
34.3 + 0.81
41.1 + 0.98
25.5 + 0.5
29.8 + 0.7
30.7 + 1.1
34.9 + 1.0
25.6 + 0.8
36.7 ± 1.0
25.1 ± 0.7
29.9 ± 0.8
25.5 ± 0.6
31.7 ± 0.5
P < 0.0001
P < 0.0001
P < 0.0001
P < 0.0001
P < 0.0001
P < 0.0001
P = 0.0021
P <0.0001
P <0.0001
P < 0.0001
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Table S1. Lifespan Data.
Strain and Condition # Deaths/# Censored Mean I s.e.m P-value vs.
(# Trials) AL Control
N2 in 2.5xl0' cfu/ml ("AL") 563/23(11) 25.5 ± 0.2
N2 in 1.7x108 cfu/ml 22/31(1) 25.6 + 1.0
N2 in 8.5x10 7 cfu/ml 25/27(1) 33.0 ± 1.0
N2 in 5.7x107 cfu/ml 51/1(1) 34.9 - 0.7
N2 in 2.5x10 7 efu/ml ("DR") 513/15(10) 33.2 0.2 P <0.0001
N2 in 2.5x10 6 cfu/ml 56/0(1) 25.9 ± 0.6
sek-1(km4) in 2.5x108 cfu/ml ("AL") 290/13(6) 20.4 + 0.2
sek-l(km4) in 2.5x10 7 cfu/ml ("DR") 259/10(5) 21.2 + 0.3 P = 0.0185
sek-l(km4) in 2.5x10 6 cfu/ml 39/5(1) 22.3 + 1.0
sek-l(km4) in 2.5x10 5 cfu/ml 50/0(1) 20.5 + 0.7
sek-l(agl) AL 48/4(1) 23.4 ± 0.7
sek-l(agl) DR 53/2(1) 25.4 + 0.7 P = 0.0158
sek-1(km4);Ex(sek-1) #1 AL 48/2(1) 24.6 ± 0.7
sek-l(km4);Ex(sek-1) #1 DR 51/0(1) 30.7 ± 0.8 P < 0.0001
sek-1(km4);Ex(sek-1) #2 AL 51/2(1) 24.2 + 0.5
sek-l(km4);Ex(sek-1) #2 DR 51/2(1) 33.0 + 0.7 P < 0.0001
N2 on plates 152/4(3) 22.7 + 0.4
daf-2(e1370) on plates 47/3(1) 40.2 + 1.1 P < 0.0001 b
sek-1(km4) on plates 138/10(3) 17.0 + 0.2
sek-1(km4);daf-2(el370) on plates 43/4(1) 26.4 + 1.5 P < 0.0001 b
nsy-1(ky397) AL 40/1(1) 22.3 + 0.7
nsy-1(ky397) CR 45/1(1) 21.8 + 0.7 P = 0.6937
unc-43(n1186) ALa 52/1(1) 27.1 + 0.5
unc-43(n1186) DRa 51/2(1) 32.4 + 0.7 P < 0.0001
pmk-l(km25) ALa 56/1(1) 21.7 + 0.6
pmk-1(km25) DRa 33/6(1) 28.0 + 1.1 P < 0.0001
pmk-3(ok169) ALa 46/7(1) 23.7 + 0.8
pmk-3(ok]69) DRa 48/6(1) 30.0 + 0.9 P < 0.0001
sek-1(km4);Ex(gpa-4p::sek-1::gfp) #1 AL 57/1(1) 22.0 + 0.7
sek-1(km4);Ex(gpa-4p::sek-1::gfp) #1 DR 52/2(1) 29.3 + 0.8 P < 0.0001
sek-l(km4);Ex(gpa-4p::sek-l::gfp) #2 AL 52/2(1) 22.3 + 0.5
sek-1(km4);Ex(gpa-4p::sek-l::gfp) #2 DR 55/0(1) 30.2 + 0.9 P < 0.0001
sek-1(km4);Ex(ges-lp::sek-1::gfp) #1 AL 49/1(1) 25.2 + 0.6
sek-1(km4);Ex(ges-1p::sek-1::gfp) #1 DR 50/2(1) 26.6 + 0.7 P = 0.0231
sek-1(km4);Ex(ges-lp::sek-1::gfp) #2 AL 53/0(1) 24.2 + 0.6
sek-1(km4);Ex(ges-lp::sek-l::gfp) #2 DR 54/1(1) 26.2 + 0.7 P = 0.0064
Shaded bars indicate the conditions used for all subsequent AL and DR lifespans.
aThis survival curve is not shown in the figures.
bThis p-value is versus the strain that immediately precedes it.
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Figure 1. Activity of the MAPKK sek-1 is Required for Multiple Physiological
Responses to DR
(A) Wild-type N2 animals exhibited an increased mean lifespan with a maximum at an
optimal level of DR, but mean lifespan of sek-1(km4) was not modulated by food level.
Errors are s.e.m. The lifespan results in this and all subsequent figures represent
combined data from independent experiments as indicated in Supplementary Table S1.
Complete lifespan data are presented in Supplementary Table S1.
(B) Two different sek-1 alleles had severely impaired DR-induced longevity response.
(C) The lifespan defects of sek-l(km4) were rescued by an extrachromosomal transgene
carrying 10 kb of the wild-type sek-1 genomic region.
(D) A mutant in nsy-1, a MAPKKK that acts immediately upstream of sek-1, exhibited
identical longevity defects to sek-l(km4).
(E) Relative to the wild-type, day 3 adult sek-l(km4) animals had a reduced respiration
rate under AL conditions and, unlike the wild-type, respiration rate was not increased
under DR. Both of these defects were rescued by a wild-type sek-1 transgene. Data
shown was pooled from four independent trials for N2 and sek-1, and two independent
trials for sek-1;Ex(sek-1), with measurements made in triplicate in each trial. Error bars
show s.e.m.
(F) High intestinal fat level in the wild-type is reduced by DR, but sek-l(km4) has a
constitutively low level of fat that is not altered by DR. The graph shows quantification
of individuals with any detectable intestinal fat on day 3 of AL or DR. Similar results
were obtained on later days (not shown). Data is pooled from two independent trials with
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more than 30 animals examined in each trial. Errors are s.e.m. Fat was detected by Sudan
Black staining; see Figure S2 for photographs of representative stained animals.
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Figure 2. sek-l Regulates skn-1 in the ASI Neurons
(A) The sek-I genomic locus is shown, with exons in pink and untranslated regions in
grey. The location of the agl mutation and the extent of the km4 deletion are shown in
red. The 10 kb genomic fragment contained in the transgene used for the rescue
experiments in Figure 1 is shown in blue. gels7[sek-l::gfp] is indicated in green and
comprises 7.6 kb of genomic DNA sequence, including sek-1 and its promoter,
translationally fused to the 5' end of a GFP cassette, the 3' end of which is fused to 1.0
kb of 3' sek-1 sequence.
(B) The gels7[sek-l::gfp] reporter expressed in many, though not all, neurons, and in the
intestine, spermathecae, and distal tip cells. Four independent integrants of this transgene
were examined with similar results. Scale bar, 100 [tm.
(C) The gels7[sek-l::gfp] reporter expressed SEK- 1::GFP in the ASI neurons. Upper
right shows animals with amphid neurons marked by uptake of the red fluorescent
lipophilic dye DiI. Lower left shows green fluorescence from SEK-1::GFP. Lower right
shows merged images, demonstrating double fluorescence in the ASI neuron. Scale bar,
10 [pm.
(D) Expression of the integrated skn-l::gfp reporter Is007 was present in most day 5 adult
wild-type animals, but absent in most sek-1 animals. This defect was rescued by an ASI-
specific gpa-4p::sek-l::rfp transgene, and was independent of the MAPK pmk-1. Each
graphed value represents pooled data from two independent trials of greater than 30
animals each. Errors are s.e.m.
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(E) ASI fluorescence intensity was greatly reduced in day 5 adult sek-1;Is007 animals,
which express SKN-1::GFP from its native promoter, but not in sek-1;gels8 animals that
express SKN- 1::GFP from the gpa-4 promoter. Each graphed value represents pooled
data from two independent trials of greater than 25 animals each. Errors are s.e.m.
(F) SKN-1::GFP fluorescence intensity was increased by DR in the ASI neurons ofls007
animals, but not sek-l(km4);Is007 animals. Each graphed value represents pooled data
from three independent trials for Is007 and two independent trials for sek-1;Is007, with
greater than 30 animals examined in each trial. Errors are s.e.m.
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Figure 3. sek-1 Acts in Two Separate Tissues to Affect Lifespan in Two Different
Ways.
(A) Two independent transformed lines carrying the ASI-specific gpa-4p::sek-l::gfp
transgene showed full rescue of the DR-induced longevity defect of sek-1(km4), but the
short basal lifespan was not rescued.
(B) Two independent transformed lines carrying the intestine-specific ges-lp::sek-l::gfp
transgene showed rescue of the short basal lifespan defect of sek-1 (km4), but the DR
longevity response defect was not rescued.
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Figure 4. Model: Separate effects of sek-1 on Lifespan in the ASI Neurons and
Intestine
sek-1 modulates lifespan in two separate tissues in two different ways. First, in the
intestine, sek-l functions downstream of nsy-1 to ensure normal basal longevity. Second,
during DR, nsy-1 and sek-1 act in the ASI neurons to increase skn-1 transcription, thereby
activating the: increased longevity response to DR. sek-1 may directly mediate the effects
of DR on skn-1 expression, or DR may modulate skn-1 expression in parallel to sek-1.
Because elevated expression of sek-1 or skn-1 in the ASI neurons is not by itself
sufficient to increase lifespan in the absence of DR (N.B. and L.G., unpublished
observations), DR must activate an as yet unidentified genetic pathway(s) in the ASI
neurons or other cells that act in parallel to skn-1 to increase longevity.
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Figure SI. The sek-1(km4) Mutation Does Not Place an Upper Bound on Lifespan.
The lifespan of sek-1(km4) animals could be extended by introduction of the daf-
2(e1370) mutation.
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Figure S2. sek-l(km4) Uncouples Fat Storage From Dietary Conditions.
Representative day 3 adult animals cultured in AL or DR conditions, with fat stained by
Sudan Black. Upper panels: Staining is observed in the anterior gut of AL wild-type
animals (black arrows), but is reduced or invisible in DR wild-type animals (white
arrowhead). Lower panels: sek-l(km4) mutants exhibit a low level of fat, comparable to
DR wild-type worms, in both AL and DR conditions (white arrowheads; see Figure 1F
for quantification). Staining is also visible in intrauterine eggs in all conditions. Scale
bars, 100 [tm.
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Figure S3. Ex(gpa-4p::sek-1::rfp) is Specifically Expressed in the ASI Neurons.
Upper left, Nomarski image of a sek-1(km4);Is007[skn-l::gfp];Ex(gpa-4p::sek-1::rfp)
animal. Upper right, red channel shows SEK- 1::RFP expression in the ASI neuron only.
Lower left, green channel confirms identity of ASI neuron via nuclear SKN-1::GFP
expression. Lower right, merged red and green channels. Scale bars, 10 ptm.
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CHAPTER 4
Conclusions and Future Directions
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Summary of Results
The overall conclusions of this work are diagrammed in Figure 1. The ASI
neurons integrate as-yet-unidentified signals of organismal energy status to detect DR.
These signals include some sort of intrinsic cues, either detection of intracellular energy
status within the ASI, or afferent hormonal signals of peripheral energy status, or both.
These intrinsic signals may be integrated with sensory perception of available food in the
environment to ultimately permit detection of restricted organismal energy availability by
the ASI neurons. Following detection of the DR state, skn-1 is activated in the ASI
neurons. This activation depends on the nsy-1/sek-1 signaling cascade in the ASI neurons,
though it remains undetermined whether nsy-1 and sek-1 act downstream of or in parallel
to DR in regulating skn-1. Upon activation during DR, skn-1 mediates appropriate cell-
nonautonomous signals from the ASI neurons to peripheral tissues to promote increased
respiration and longer lifespan. These signals are likely hormonal in nature, given the
established endocrine functions of the ASI neurons. Because ASI-specific
overexpression of skn-1 is insufficient to increase lifespan by itself, another genetic
pathway(s) must be required to act in parallel to skn-1 to mediate the DR longevity
response. This additional pathway may function in the ASIs or in other neuron(s).
Future Research Directions
Inspection of Figure 1 will reveal that many unanswered questions have been
raised in the course of this work. Here, I will attempt to identify some of the more
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important directions for future research on the control of DR longevity by skn-1 and the
ASI neurons.
What are the signals of energy status integrated by the ASI neurons?
An analogy to mammalian studies suggests that there are three general categories
of cues that can modulate neuronal energy status detection (see also Chapter 1):
environmental sensory perception, afferent hormonal signals from the periphery, and
intracellular energy status monitoring. We have little information thus far as to the nature
of the signals influencing the ASI neurons to adopt the DR response.
Chemosensory perception of the external environment is not required for a normal
response to DR, since two different cilia-defective mutants that lack all chemosensory
capability, che-3 and osm-5, increased lifespan normally during DR (Chapter 2).
However, che-3 mutation does downregulate a skn-l::gfp reporter in the ASI neurons in
certain environments (Figure 2). Therefore, the possibility exists that sensory perception,
though not required for DR longevity, may be capable of suppressing it in some
environments, as has been observed in flies'. One potential means of addressing the
modulatory capability of sensory perception during DR would be to combine the bacterial
density control method developed in this work with pharyngeal pumping-deficient
mutants such as eat-2 to separate environmental and intrinsic energy restriction.
The intrinsic pathways affecting DR detection in the ASI neurons might be best
identified by generating ASI-specific RNAi knockdown strains composed of an shRNA
against the target of interest driven by an ASI-specific promoter and injected into an
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RNAi spreading-defective mutant such as sid-1. Crucial metabolic enzymes involved in
cell-intrinsic energy sensing in mammals, such as mTOR, AMPK, and acetyl-CoA
carboxylase could be targeted to examine the effects of cellular energy sensing in the
ASIs on basal and DR longevity. Similarly, RNAi against candidate hormone receptors in
the ASIs could be used to screen for important afferent hormonal factors.
An additional possible type of initiating event in DR perception by the ASI is
suggested by the particular genes this work has identified. nsy-1 and sek-1 are
homologous to mammalian ASK1 and MEK6, respectively, and both the worm and
mammalian homologues are known to be important in stress responses, such as ER stress,
reactive oxygen species (ROS), and signaling from receptors that use ROS as a second
messenger 2. Similarly, both worm skn-1 and the homologous mammalian Nrf proteins are
known to be involved in stress response and xenobiotic detoxification, and Nrf2 is a
crucial mediator of the ER stress response 3'4. Therefore, it may be that one of the inputs
initiating skn.-l-mediated DR perception in the ASI neurons is some sort of stress signal
caused by low energy availability, such as, for instance, unfolded proteins in the ER. In
other words, DR may be detected by activation of general stress-responsive pathways in
response to nutrient limitation. This hypothesis warrants further investigation.
What genes act downstream ofsek- 1 and skn-1 to mediate DR longevity?
Since the MAPKK sek-1 appears to regulate skn-1 at the transcriptional level,
there is presumably a MAPK(s) and a transcription factor(s) connecting sek-1 and skn-1.
These remain to be identified. Since the mammalian homologue of sek-1 exclusively
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activates p38 MAPKs5, the most likely candidates are the worm p38 MAPK homologues,
pmk-1, -2, and -3 6. In fact, sek-1 is known to be a critical regulator ofpmk-i in the
intestine7 . However, deletion alleles ofpmk- or pmk-3 failed to reproduce the ASI skn-
1::gfp expression defect of sek-1 (Chapter 3). Therefore, pmk-2 is a strong candidate, but
could not be tested because the only available deletion strain arrests during larval
development. Alternately, more than one MAPK might act redundantly to regulate skn-1.
Future availability of additional deletion alleles may permit identification of the genes
connecting sek-1 and skn-1 in the ASI neurons.
An important goal of future work will be to identify the crucial genes regulated by
skn-1 in the ASIs to mediate DR longevity, and the cell nonautonomous signals released
by the ASIs during DR. Possible clues as to the identity of these genes were provided by
a computerized scan for skn-1 consensus binding sites in the promoter regions of all
predicted genes in the C. elegans genome (the promoter-scanning Perl script, written by
the author, is available upon request). The 168 genes with eight or more predicted
binding sites are presented in Figure 3 (representing < 1% of genes in the genome; the
full list is available from the author on request). Because of the degenerate nature of the
skn-1 consensus site, this list will necessarily contain many false positives. However, the
bonafide skn-1 target dod-24 was identified using this scan (Chapter 2), validating the
presence of true positives in the list. Strikingly, of the 97 genes that could be assigned a
predicted function based on homology to proteins of known function, 33 (34%) are likely
to function in regulation of energy balance, either in neuronal perception of food
availability, production of hormones or neuropeptides, or response to hormones or
neuropeptides. In particular, the scan predicts skn-1 regulation of several genes whose
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mammalian homologues are known to be critical in regulation of feeding and energy
balance, including receptors for hypocretin, neuropeptide FF, thyrotropin, somatostatin,
ghrelin, and progestin, as well as the nuclear hormone receptor hepatocyte nuclear factor-
4 and glucocorticoid modulatory element binding protein. These predicted skn-1 targets
provide a good starting point for experimental validation of crucial skn-l-dependent
genes, and suggest that skn-1 may broadly modulate endocrine properties of the ASI
neurons during DR.
Interestingly, a mammalian master regulator of xenobiotic detoxification
enzymes, CAR, which is expressed in liver, intestine, and brain, is induced by fasting in
mice and is required for normal neuroendocrine adaptation to DR8 . This suggests a
possible conserved role of certain xenobiotic detoxification genes in regulation of
endocrine responses to DR. The significance of such a functional overlap is unclear, but
certainly intriguing.
What hormone(s) mediate the DR longevity response?
To identify hormones mediating the DR response, I would suggest using the
metabolic alteration of peripheral tissues as a proxy phenotype in lieu of lifespan analysis
of screening purposes. Direct measurement of oxygen consumption is prohibitively time-
and labor-intensive, but some sort of visible reporter indicating peripheral mitochondrial
respiration could be developed. For example, a fluorescent electron-transport chain
subunit might serve9. This reporter should indicate a skn-l-dependent respiration increase
in response to DR. Then, a mutant screen for animals that fail to increase respiration
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during DR, followed by a secondary test of lifespan response, might permit identification
of critical hormonal signals. Alternately, many hormonal expression patterns have been
determined, including many expressed in the ASI neurons. ASI-specific RNAi of
candidate hormones (as described above) might identify those essential for DR. It is
worth noting that DR seems to extend lifespan more effectively in a daf-2 mutant
background, and less effectively in a daf-9 mutant background, possibly implicating
insulin-like and steroidal hormones as negative and positive regulators of DR longevity,
respectively.
What other genetic pathways are required for DR longevity?
Overexpression of skn-1 in the ASI neurons does not extend lifespan by itself, so
another genetic pathway(s) is apparently required to act in parallel to skn-1 to induce the
DR longevity response. Various approaches could be employed to try and identify these.
Ablation of neurons other than the ASIs might reveal additional neurons that are required
for a normal DR longevity response, providing a good starting point for further analysis.
Alternately, mutant screens in a strain overexpressing skn-1 in the ASIs might uncover
genes acting in parallel to increase respiration and lifespan.
Conclusions
The discovery that central neuroendocrine cells, known to be critical in
integrating organismal energy status, coordinate metabolic and lifespan responses to DR
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by cell-nonautonomous signaling is an important conceptual advance in the mechanistic
understanding of DR longevity in metazoans. Prior to this work, essentially the only
model system in which the mechanism of DR was understood at the genetic level was the
unicellular yeast'0 . Therefore, though it has been known for many years that DR produces
dramatic alterations in neuroendocrine signaling in mammals", no causative role of any
cell-nonautonomous signal in coordinating the response to DR had been demonstrated. In
fact, until recent years, the most popular theories to explain DR longevity tended to
suggest that the phenomenon was an essentially passive byproduct of altered metabolism
during DR, resultant from, for example, reduced ROS production, rather than being an
actively regulated longevity response in times of low nutrition' 2. The demonstration that
DR longevity results from increased activity of specific effectors in yeast has brought
most of the field around to the idea that DR longevity is a coordinated response to low
nutrition, but most contemporary theories still regard it as a basically cell-autonomous
phenomenon., brought on by changes in cellular metabolism' 2 . The discovery in the
present work that a single pair of neurons plays a critical role in sensing DR and
coordinating organismal metabolic and lifespan responses strongly argues that DR
longevity is an active survival program that is engaged in times of low nutrient
availability, rather than some mere accident of altered peripheral metabolism.
The recent demonstration that Drosophila olfaction is sufficient to partially
suppress DR longevity provides further evidence for the critical role of neurons in DR,
and suggests that neuronal control of DR longevity is evolutionarily conserved'. This
notion has important implications for mammalian aging biology, since DR is the most
robust lifespan-increasing intervention known in mammals. Quite a lot is known about
205
how the hypothalamus reflexively controls organismal energy balance, and the
hypothalamus is also a critical center of lifespan control in the mammal (Chapter 1 and
references therein). It will be interesting to see whether future work can connect these
two areas of knowledge, hypothalamic energy sensing and hypothalamic lifespan control,
to show that the hypothalamus coordinates mammalian responses to DR. It may be hoped
that one day, pharmacological activators of these putative hypothalamic DR longevity
pathways might be developed, permitting longer, more disease-free life for humankind.
206
References
1. Libert, S., Zwiener, J., Chu, X., Vanvoorhies, W., Roman, G. & Pletcher, S. D.
Regulation of Drosophila life span by olfaction and food-derived odors. Science 315,
1133-7 (2007).
2. Hayakawa, T., Matsuzawa, A., Noguchi, T., Takeda, K. & Ichijo, H. The ASKI-MAP
kinase pathways in immune and stress responses. Microbes Infect 8, 1098-107 (2006).
3. An, J.H. & Blackwell, T.K. SKN-1 links C. elegans mesendodermal specification to a
conserved oxidative stress response. Genes Dev 17, 1882-93 (2003).
4. Motohashi, H. & Yamamoto, M. Nrf2-Keapl defines a physiologically important
stress response mechanism. Trends Mol Med 10, 549-57 (2004).
5. Roux, P.P. & Blenis, J. ERK and p38 MAPK-activated protein kinases: a family of
protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68, 320-44
(2004).
6. Berman, K., McKay, J., Avery, L. & Cobb, M. Isolation and characterization ofpmk-
(1-3): three p38 homologs in Caenorhabditis elegans. Mol Cell Biol Res Commun 4, 337-
44 (2001).
7. Inoue, H., Hisamoto, N., An, J. H., Oliveira, R. P., Nishida, E., Blackwell, T. K. &
Matsumoto, K. The C. elegans p38 MAPK pathway regulates nuclear localization of the
transcription factor SKN-1 in oxidative stress response. Genes Dev 19, 2278-83 (2005).
8. Maglich, J.M., Watson, J., McMillen, P. J., Goodwin, B., Willson, T. M. & Moore, J.
T. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric
restriction. J Biol Chem 279, 19832-8 (2004).
9. Kayser, E.B., Morgan, P.G., Hoppel, C.L. & Sedensky, M.M. Mitochondrial
expression and function of GAS-1 in Caenorhabditis elegans. J Biol Chem 276, 20551-8
(2001).
10. Dilova, I., Easlon, E. & Lin, S.J. Calorie restriction and the nutrient sensing signaling
pathways. Cell Mol Life Sci 64, 752-67 (2007).
11. Mobbs, C.V., Bray, G. A., Atkinson, R. L., Bartke, A., Finch, C. E., Maratos-Flier,
E., Crawley, J. N. & Nelson, J. F. Neuroendocrine and pharmacological manipulations to
assess how caloric restriction increases life span. J Gerontol A Biol Sci Med Sci 56 Spec
No 1, 34-44 (2001).
12. Sinclair, D.A. Toward a unified theory of caloric restriction and longevity regulation.
Mech Ageing Dev 126, 987-1002 (2005).
207
208
Figure 1. Model of ASI neuronal function during DR.
DR is sensed by integration in the ASI neurons of intrinsic signals related to energy
status, which may include intracellular energy sensing and/or afferent hormonal signals
from the periphery. Sensory perception of food in the environment may also influence
the DR decision. Following the detection of an energy-restricted organismal state, skn-1
is activated in the ASIs. Activation of skn-1 depends on cell-autonomous activity of the
nsy-1/sek-1 MAPKK signaling module, which may function downstream of or in parallel
to DR. Active skn-1 then promotes a cell non-autonomous signal to peripheral tissues that
increases respiration rate and extends lifespan. At least one additional genetic pathway,
which has not yet been identified, is likely to function in the ASIs and/or other neurons in
parallel to the skn-1 pathway to promote DR longevity.
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Figure 2. Sensory cilia defective mutant che-3(e1124) disrupts normal skn-l::gfp
expression in the ASI neurons under certain environmental conditions.
skn-1::gfp expression is substantially reduced by che-3 mutation under standard plate
conditions, but not under the AL or DR liquid culture conditions. Animals were assayed
on day 5 of adulthood. Each graphed value represents the mean of two trials; errors are
s.e.m. n in trial 1, 2: Is007 plate: 36, 31; che-3;Is007 plate: 33, 37; Is007 AL: 21, 26; che-
3;Is007: 20, 36; Is007 DR: 21, 29; che-3;Is007 DR: 19, 28.
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Figure 3. Predicted skn-I transcriptional target genes.
Both strands of the 5' 1000 bp of each predicted gene in the C. elegans genome
(Wormbase) was scanned for the skn-1 consensus binding site WWTRTCAT, where W =
T or A and R = G or A (see ref. 3). One mismatch was permitted in the first three bases.
All genes with eight or more predicted binding sites are listed, with functional
annotations, where possible, principally based on homology to mammalian genes with
known function. Shaded rows indicate genes likely to be involved in neuronal perception
of food availability, production of hormones or neuropeptides, or response to hormones
or neuropeptides. One predicted gene, dod-24 (dashed box) has been experimentally
confirmed to be a bonafide skn-1 target. The others have not been experimentally tested.
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023G010.5
F42AI0.7.1
F42Ai0.7.2
M01F1.7
T16H12.Sb.1
Y39A1B 1
ZK688.6a.2
COSA83
C08811.!
C0W5H.7
C41C4.5.2
C52A11.3
DH11.5Sa
EEED8.2
F10G72
F11G11 3
F49E12.11
H43E18.1
K02E7.10
R07G3.7a
R07G3.7b
ROBD1.11
T01H3.2
Y480A.4
ZK822.34d.3
Name O IShtePredicted Fikq#"
8
8
sr -307 8
8
S
cob-iSbte-4
OWr-88
syn- 73
tax-B
dec-75
cW- 75
both-43
tap-282
zyg-if
unc-f1,
tsn-I
get-B
eat-2
amt-I
a8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
5 8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
unknown
unknown
pstjfdtogen
~ b~M
unknown
unknown
.,,-
unknown
unknown
DNA reair (RAD214-ie)
anion/bicarbonate exchange transporter
unknown
cysteine protease cathepein F
cystene protease cathepen F
transcrpton elongation factor B subunit-like
mkroRNA
unknown
lectirn
unknown
unknown
syntaxin
guanine nucleotide exchange factor
guanine nudceotid exchange factor
unknown
calcineuin
unknown
paeudogene
pseoudogene
unknown
Zn-finger
unknown
adenylate kinase (purine metabolim)
adenylat kinase (purine metabolism)
unknown
unknown
unknown
unknown
unknown
lecin
lectin
DNA ligase III
unknown
unknown
unknown
unknown
unknown
phospetidynoati tramnslor protein
speckdetype POZ protein
lectin
m8 alutetne -one (1tera0 Synthesis)
Prolyl•arboxytpopies
hypodermal antigen OV17
serinethoonine protein kinase
chillness
iopn-chanel (dgenerin)
PDZ doma protein
unknown
unknown
transcriptional oactivator p100
glutathone S-transferase
microRNA
unknown
cystene protese cathepsn L
unknown
unknown
chitnas
unknown
acetyPchdine receptor (pharyngeal pumping rte)
phonphonevthane o n mtahvftransftrsa
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APPENDIX 1
Additional Mutants Tested for a Role in DR Longevity
This chapter consists of a table listing some additional mutants that were tested for a role
in DR longevity and that do not appear elsewhere in this thesis.
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Table 1. Additional mutants tested for a role in DR longevity.
Strain and Condition # Deaths/# Censored Mean ± s.e.m P-value vs.
(# Trials) AL Control
N2 AL 832/50(17) 25.7 ± 0.1
N2 DR 792/60(16) 32.8 ± 0.2 P < 0.0001
sra-13(zhl3) AL 49/3(1) 24.9 + 0.6
sra-13(zhl3) DR 47/5(1) 35.0 + 0.9 P < 0.0001
geln3[sir-2.1;rol-6(sul 006)/ AL 48/6(1) 30.1 + 1.0
geln3fsir-2.1;rol-6(sul006)/ DR 52/4(1) 36.7 ± 0.7 P < 0.0001
jkk-1(km2) AL 46/4(1) 21.8 + 0.6
ikk-1(km2) DR 40/5(1) 26.4 + 0.6 P < 0.0001
mek-1(ks54) ALa 26/23(1) _10a
mek-1(ks54) DRa 17/27(1) ~10" P = 0.3625
sir-2.1(pk1640::Tcl) AL 100/3(2) 25.8 ± 0.5
sir-2.1(pkl640::Tcl) DR 100/5(2) 28.0 + 0.5 P < 0.0001
crh-](n3315) AL 50/5(1) 23.6 + 0.8
crh-1(n3315) DR 38/2(1) 30.3 + 0.9 P < 0.0001
isp-l(qml50) AL 54/1(1) 23.2 + 0.8
isp-l(qml50) DR 49/5(1) 27.8 + 0.7 P < 0.0001
unc-43(n498sd) AL 48/4(1) 22.7 + 0.8
unc-43(n498sd) DR 51/1(1) 26.4 + 0.6 P = 0.0033
ctb-l(qml89) ALb 23/28(1) -27b
ctb-l(qml89) DRb 3/49(1) >>27b  P < 0.0001
isp-i(qml50);ctb-1(qm189) ALb 23/28(1) -2 7b
isp-i(qmI50);ctb-l(qmi89) DRb 3/49(1) >>27b P < 0.0001
aak-2(ok524) ALe 32/24(1) -20c
aak-2(ok524) D)RC 7/46(1) >>20c P < 0.0001
kat-1(n4430) AL 62/2(1) 24.4 + 0.5
kat-1(n4430) DR 44/12(1) 28.4 + 0.9 P < 0.0001
daf-28(saI91) AL 46/0(1) 25.6 + 0.6
daf-28(sa191) :DR 52/0(1) 31.0 + 0.8 P < 0.0001
daf-7(el372) AL 52/0(1) 24.1 + 0.7
daf-7(e1372) DR 50/0(1) 32.6 + 0.6 P < 0.0001
daf-7(m62) AL 43/0(1) 23.4 ± 0.5
daf-7(m62) DR 47/4(1) 30.7 + 0.5 P < 0.0001
aLifespan only followed to day 10; mean is an approximation.
bLifespan only followed to day 27; mean is an approximation.
CLifespan only followed to day 20; mean is an approximation.
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